Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
1000,,5154977,CHEMBL1665986,Antibacterial activity against Escherichia coli TOP10 harboring beta-lactamase RTG4 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1001,,5154978,CHEMBL1665988,Antibacterial activity against Escherichia coli TOP10 harboring recombinant plasmid RTG4-S69 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1002,,5154979,CHEMBL1665990,Antibacterial activity against Escherichia coli TOP10 harboring recombinant plasmid RTG4-V49 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1003,,5154980,CHEMBL1666863,Antibacterial activity against Escherichia coli TOP10 harboring recombinant plasmid RTG4-S69-V49 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1004,,5154981,CHEMBL1666865,Antibacterial activity against Escherichia coli TOP10 harboring beta-lactamase RTG3 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1005,,5154982,CHEMBL1666867,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1006,,5155023,CHEMBL1666881,Activity of recombinant beta-lactamase RTG4 expressed in Escherichia coli TOP10 by nitrocefin hydrolysis assay,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326751,<,1,0,<,Kcat,/s,0.01,CHEMBL612545,,Unchecked,,,Kcat,/s,,0.01
1007,,5155024,CHEMBL1666882,Activity of recombinant beta-lactamase RTG4 expressed in Escherichia coli TOP10 by nitrocefin hydrolysis assay relative to benzylpenicillin,B,BAO_0001103,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1326751,<,1,0,<,Activity,%,0.01,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,0.01
1008,Not Determined,5155025,CHEMBL1666881,Activity of recombinant beta-lactamase RTG4 expressed in Escherichia coli TOP10 by nitrocefin hydrolysis assay,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326751,,1,0,,Km,,,CHEMBL612545,,Unchecked,,,Km,,,
1009,,5156850,CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325748,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.016
1010,,5156861,CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325748,=,1,1,=,MIC50,ug.mL-1,0.047,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.047
1011,,5156872,CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325748,=,1,1,=,MIC90,ug.mL-1,0.094,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.094
1012,,5156883,CHEMBL1661858,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent susceptible isolates by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1325748,=,1,0,=,Activity,%,99.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,99.0
1013,,5156894,CHEMBL1661859,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent intermediate isolates by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1325748,=,1,0,=,Activity,%,1.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,1.0
1014,,5156905,CHEMBL1662505,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent resistant isolates by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1325748,=,1,0,=,Activity,%,0.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,0.0
1015,,5157303,CHEMBL1660782,Activity of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649429,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326171,=,1,0,=,Kcat,/s,292.0,CHEMBL1667678,Salmonella enterica subsp. enterica serovar Westhampton,Extended-spectrum beta-lactamase CTX-M-53,356621.0,,Kcat,/s,,292.0
1016,,5157313,CHEMBL1660783,Ratio of Kcat/Km for Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,B,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649429,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326171,=,1,0,=,Kcat/Km,/s/microM,3.6,CHEMBL1667678,Salmonella enterica subsp. enterica serovar Westhampton,Extended-spectrum beta-lactamase CTX-M-53,356621.0,,Kcat/Km,/s/microM,,3.6
1017,,5157329,CHEMBL1660782,Activity of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649429,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1326171,=,1,1,=,Km,nM,80000.0,CHEMBL1667678,Salmonella enterica subsp. enterica serovar Westhampton,Extended-spectrum beta-lactamase CTX-M-53,356621.0,,Km,uM,UO_0000065,80.0
1018,,5158731,CHEMBL1662780,Ratio of MIC for beta-lactamase-negative methicillin-susceptible Staphylococcus aureus ATCC 25923 by microdilution method at pH 7.4 to ratio of MIC for beta-lactamase-negative methicillin-susceptible Staphylococcus aureus ATCC 25923 by microdilution method at pH 5.5,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,FC,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,16.0
1019,,5158732,CHEMBL1662781,Ratio of MIC for hospital-acquired methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method at pH 7.4 to ratio of MIC for hospital-acquired methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method at pH 5.5,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,FC,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,128.0
1020,,5158733,CHEMBL1662782,Ratio of MIC for hospital-acquired methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method at pH 5.5 to MIC for beta-lactamase-negative methicillin-susceptible Staphylococcus aureus ATCC 25923 by microdilution method at pH 5.5,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,FC,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,4.0
1021,,5158734,CHEMBL1662783,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as bacterial count per mg of cell protein at low extracellular compound concentration after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,log10cfu,,3.23,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,3.23
1022,,5158735,CHEMBL1662784,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as bacterial count per mg of cell protein at high extracellular compound concentration after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,log10cfu,,-0.42,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-0.42
1023,,5158736,CHEMBL1662785,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as change in bacterial count after 24 hrs,F,BAO_0000188,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326332,=,1,1,=,EC50,ug.mL-1,0.27,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,0.27
1024,,5158737,CHEMBL1662786,Bacteriostatic activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as change in bacterial count after 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,Activity,mg/L,0.26,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,0.26
1025,,5158738,CHEMBL1662787,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 infected in human keratinocytes assessed as bacterial count per mg of cell protein at low extracellular compound concentration after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,log10cfu,,2.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,2.75
1026,,5158739,CHEMBL1662790,Bacteriostatic activity against methicillin-resistant Staphylococcus aureus ATCC 33591 infected in human keratinocytes assessed as change in bacterial count after 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1326332,=,1,0,=,Activity,mg/L,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,200.0
1027,,5159733,CHEMBL1663037,Antibacterial activity against Staphylococcus aureus E19977 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325766,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,2.0
1028,,5159752,CHEMBL1661769,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 20 mg/liter upto 24 hrs by time-kill study,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,>,1,0,>,FC,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,2.0
1029,,5159758,CHEMBL1661764,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter after 12 hrs by time-kill study,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,=,1,0,=,FC,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,2.0
1030,,5159760,CHEMBL1661767,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter upto 24 hrs by time-kill study,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,=,1,0,=,FC,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,2.0
1031,,5159762,CHEMBL1661768,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 1.5 mg/liter upto 24 hrs by time-kill study,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,=,1,0,=,FC,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,2.0
1032,Not Active,5159772,CHEMBL1661770,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 9 mg/liter after 24 hrs by time-kill study,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1033,Not Active,5159776,CHEMBL1661771,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter after 24 hrs by time-kill study,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1034,Not Active,5159780,CHEMBL1661772,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 1.5 mg/liter after 24 hrs by time-kill study,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1035,Not Active,5159784,CHEMBL1661773,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 20 mg/liter after 24 hrs by time-kill study,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1036,Not Active,5159788,CHEMBL1661774,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 0.5 mg/liter after 24 hrs by time-kill study,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1037,Not Active,5159807,CHEMBL1661776,"Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in intracellular bacterial cfu in peritoneum at 200 mg/kg, sc administered 2 hrs after infection measured after 4 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1038,Active,5159808,CHEMBL1661775,"Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in bacterial cfu in peritoneum at 200 mg/kg, sc administered 2 hrs after infection measured after 4 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1039,Active,5159809,CHEMBL1661883,"Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in extracellular bacterial cfu in peritoneum at 200 mg/kg, sc administered 2 hrs after infection measured after 4 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1325766,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1040,,5163846,CHEMBL1654220,Antibacterial activity against Escherichia coli 1285 harboring beta-lactamase CMY-33 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1041,,5163855,CHEMBL1654221,Antibacterial activity against Escherichia coli YD006 harboring beta-lactamase CMY-33 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,96.0
1042,,5163864,CHEMBL1654222,Antibacterial activity against Escherichia coli 34943 harboring beta-lactamase CMY-44 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1043,,5163873,CHEMBL1654223,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK carrying beta-lactamase CMY-33 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1044,,5163882,CHEMBL1654224,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK carrying beta-lactamase CMY-44 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
1045,,5163891,CHEMBL1654225,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK carrying beta-lactamase CMY-2 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1046,,5163900,CHEMBL1654226,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.0
1047,,5163930,CHEMBL1655015,Antimicrobial activity against Stenotrophomonas maltophilia KJ by twofold serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,MIC,ug.mL-1,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,2048.0
1048,,5163939,CHEMBL1655016,Antimicrobial activity against ampD1-deficient Stenotrophomonas maltophilia KJ by twofold serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,MIC,ug.mL-1,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,2048.0
1049,,5163948,CHEMBL1655017,Antimicrobial activity against ampD2-deficient Stenotrophomonas maltophilia KJ by twofold serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,MIC,ug.mL-1,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,2048.0
1050,,5163957,CHEMBL1655018,"Antimicrobial activity against ampD1-, ampD2-deficient Stenotrophomonas maltophilia KJ by twofold serial agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,MIC,ug.mL-1,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,2048.0
1051,,5164725,CHEMBL1665013,Antibacterial activity against Campylobacter jejuni isolate P338 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1052,,5164737,CHEMBL1665014,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P790 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1053,,5164750,CHEMBL1665015,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1093 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1054,,5164761,CHEMBL1665016,Antibacterial activity against Campylobacter jejuni isolate P1093 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1055,,5164773,CHEMBL1665017,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1618 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,256.0
1056,,5164786,CHEMBL1665018,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1650 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1057,,5164799,CHEMBL1665019,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1730 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1058,,5164812,CHEMBL1665880,Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1698 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1059,,5164825,CHEMBL1665881,Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1699 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1060,,5164838,CHEMBL1665882,Antibacterial activity against bla gene-negative and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P843 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1061,,5164851,CHEMBL1665883,Antibacterial activity against bla gene-negative and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P854 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1062,,5164864,CHEMBL1665884,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter coli isolate P321 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC,ug ml-1,UO_0000274,64.0
1063,,5164877,CHEMBL1665885,Antibacterial activity against bla-positive and beta-lactamase-weakly positive Campylobacter coli isolate P1627 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC,ug ml-1,UO_0000274,64.0
1064,,5164889,CHEMBL1665886,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter coli isolate P1826 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC,ug ml-1,UO_0000274,64.0
1065,,5168274,CHEMBL1659627,Antibacterial activity against Klebsiella pneumoniae 05-560 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
1066,,5168288,CHEMBL1659628,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1067,,5168301,CHEMBL1659629,Antibacterial activity against Escherichia coli TOP10 harboring beta-lactamase NDM-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1068,,5168315,CHEMBL1659630,Antibacterial activity against Escherichia coli J53 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1069,,5168329,CHEMBL1659631,Antibacterial activity against Escherichia coli J53 harboring beta-lactamase NDM-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1070,,5168343,CHEMBL1659632,Antibacterial activity against Escherichia coli NF-NDM-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1071,,5168356,CHEMBL1659633,Activity of Klebsiella pneumoniae 05-560 beta-lactamase NDM-1 by spectrophotometry,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1322938,=,1,1,=,Km,nM,8000.0,CHEMBL1667695,Klebsiella pneumoniae,Beta-lactamase NDM-1,573.0,,Km,uM,UO_0000065,8.0
1072,,5168367,CHEMBL1659634,Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase NDM-1,B,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322938,=,1,0,=,Kcat/Km,/s/microM,0.61,CHEMBL1667695,Klebsiella pneumoniae,Beta-lactamase NDM-1,573.0,,Kcat/Km,/s/microM,,0.61
1073,,5168377,CHEMBL1659635,Activity of Klebsiella pneumoniae 05-560 beta-lactamase IMP1 by spectrophotometry,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1322938,=,1,1,=,Km,nM,37000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,37.0
1074,,5168388,CHEMBL1659636,Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase IMP1,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322938,=,1,0,=,Kcat/Km,/s/microM,0.22,CHEMBL612545,,Unchecked,,,Kcat/Km,/s/microM,,0.22
1075,,5168398,CHEMBL1659763,Activity of Klebsiella pneumoniae 05-560 beta-lactamase VIM2 by spectrophotometry,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1322938,=,1,1,=,Km,nM,22000.0,CHEMBL1667696,Klebsiella pneumoniae,Metallo-beta-lactamase VIM-2,573.0,,Km,uM,UO_0000065,22.0
1076,,5168408,CHEMBL1659764,Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase VIM2,B,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322938,=,1,0,=,Kcat/Km,/s/microM,0.55,CHEMBL1667696,Klebsiella pneumoniae,Metallo-beta-lactamase VIM-2,573.0,,Kcat/Km,/s/microM,,0.55
1077,,5168419,CHEMBL1659633,Activity of Klebsiella pneumoniae 05-560 beta-lactamase NDM-1 by spectrophotometry,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322938,=,1,0,=,Kcat,/s,5.0,CHEMBL1667695,Klebsiella pneumoniae,Beta-lactamase NDM-1,573.0,,Kcat,/s,,5.0
1078,,5168429,CHEMBL1659635,Activity of Klebsiella pneumoniae 05-560 beta-lactamase IMP1 by spectrophotometry,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322938,=,1,0,=,Kcat,/s,8.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,8.0
1079,,5168439,CHEMBL1659763,Activity of Klebsiella pneumoniae 05-560 beta-lactamase VIM2 by spectrophotometry,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322938,=,1,0,=,Kcat,/s,12.0,CHEMBL1667696,Klebsiella pneumoniae,Metallo-beta-lactamase VIM-2,573.0,,Kcat,/s,,12.0
1080,,5171039,CHEMBL1652763,Activity at Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322398,=,1,0,=,Kcat,/s,75.0,CHEMBL1667689,Chryseobacterium indologenes,Metallo-beta-lactamase IND-6,253.0,,Kcat,/s,,75.0
1081,,5171053,CHEMBL1652763,Activity at Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1322398,=,1,1,=,Km,nM,23000.0,CHEMBL1667689,Chryseobacterium indologenes,Metallo-beta-lactamase IND-6,253.0,,Km,uM,UO_0000065,23.0
1082,,5172093,CHEMBL1652764,Ratio of Kcat to Km for Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322398,=,1,0,=,Kcat/Km,10'6/M/s,3.3,CHEMBL1667689,Chryseobacterium indologenes,Metallo-beta-lactamase IND-6,253.0,,Kcat/Km,10'6/M/s,,3.3
1083,,5172121,CHEMBL1652767,Ratio of Kcat to Km for Chryseobacterium meningosepticum CCUG 4310 beta-lactamase BlaB1 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322398,=,1,0,=,Kcat/Km,10'6/M/s,1.0,CHEMBL1667692,Flavobacterium meningosepticum,Carbapenem-hydrolyzing beta-lactamase BlaB-1,238.0,,Kcat/Km,10'6/M/s,,1.0
1084,,5172135,CHEMBL1652754,Antimicrobial activity against Chryseobacterium indologenes 597 expressing metallo-beta-lactamase IND-6 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322398,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL613343,Chryseobacterium indologenes,Chryseobacterium indologenes,253.0,,MIC,ug ml-1,UO_0000274,64.0
1085,,5172136,CHEMBL1652757,Antimicrobial activity against Escherichia coli DH5alpha harboring metallo-beta-lactamase IND-6 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322398,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1086,,5172137,CHEMBL1652760,Antimicrobial activity against Escherichia coli DH5alpha harboring plasmid pBC-SK after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322398,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1087,,5180867,CHEMBL1659346,Antimicrobial activity against Acinetobacter baumannii KI by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,256.0
1088,,5180868,CHEMBL1659347,Antimicrobial activity against Acinetobacter baumannii CIP70.10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
1089,,5180869,CHEMBL1659348,Antimicrobial activity against Acinetobacter baumannii AYE expressing VEB-1 gene by Etest method,F,BAO_0002146,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,256.0
1090,,5180870,CHEMBL1659349,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1091,,5180871,CHEMBL1659350,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-50 plasmid by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
1092,,5180872,CHEMBL1659351,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1093,,5180873,CHEMBL1659352,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid with entire blaAmpC gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1094,,5180874,CHEMBL1659353,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid with entire blaAmpC gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1095,,5180875,CHEMBL1659354,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid with entire blaAmpC gene with alanine residue deletion at 215 position by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1096,,5180876,CHEMBL1659355,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid carrying entire blaAmpC gene with alanine residue insertion at 215 position by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1097,,5180877,CHEMBL1659356,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid carrying entire blaAmpC gene with alanine residue deletion at 215 position and R210P substitution by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1098,,5180878,CHEMBL1659357,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid carrying entire blaAmpC gene with alanine residue insertion at 215 position and R210P substitution by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1099,,5180879,CHEMBL1659358,Antimicrobial activity against Escherichia coli TOP10 harboring pTOPO plasmid by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1100,,5181294,CHEMBL1665519,Antibacterial activity against 5 x 10'5 CFU/ml CMY-30 producing Escherichia coli MC4100 harboring plasmid AC-cmy30 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649546,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327094,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1101,,5181295,CHEMBL1665520,Antibacterial activity against 5 x 10'5 CFU/ml CMY-2 producing Escherichia coli MC4100 harboring plasmid AC-cmy2 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649546,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327094,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1102,,5181296,CHEMBL1665521,Antibacterial activity against 5 x 10'5 CFU/ml Escherichia coli MC4100 harboring plasmid ACYC184 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649546,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327094,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1103,,5183009,CHEMBL1654491,Ratio of Kcat to Km for Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase,B,BAO_0000193,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322297,=,1,0,=,Ratio,,0.1,CHEMBL1667693,Klebsiella pneumoniae,Extended spectrum beta-lactamase CTX-M-71,573.0,,Ratio,,,0.1
1104,,5183025,CHEMBL1654492,Ratio of Kcat to Km for Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase,B,BAO_0000193,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322297,=,1,0,=,Ratio,,0.25,CHEMBL1667694,Klebsiella pneumoniae,Beta-lactamase AH27 CTX-M-15,573.0,,Ratio,,,0.25
1105,,5183047,CHEMBL1654473,Antimicrobial activity against Escherichia coli K-12 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1106,,5183066,CHEMBL1654476,Antimicrobial activity against Escherichia coli DH5[alpha] by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1107,,5183084,CHEMBL1654489,Activity of Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322297,=,1,0,=,Kcat,/s,8.8,CHEMBL1667693,Klebsiella pneumoniae,Extended spectrum beta-lactamase CTX-M-71,573.0,,Kcat,/s,,8.8
1108,,5183096,CHEMBL1654490,Activity of Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1322297,=,1,0,=,Kcat,/s,45.0,CHEMBL1667694,Klebsiella pneumoniae,Beta-lactamase AH27 CTX-M-15,573.0,,Kcat,/s,,45.0
1109,,5183107,CHEMBL1654489,Activity of Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1322297,=,1,1,=,Km,nM,85000.0,CHEMBL1667693,Klebsiella pneumoniae,Extended spectrum beta-lactamase CTX-M-71,573.0,,Km,uM,UO_0000065,85.0
1110,,5183113,CHEMBL1654490,Activity of Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1322297,=,1,1,=,Km,nM,180000.0,CHEMBL1667694,Klebsiella pneumoniae,Beta-lactamase AH27 CTX-M-15,573.0,,Km,uM,UO_0000065,180.0
1111,,5183118,CHEMBL1654472,Antimicrobial activity against Escherichia coli K-12 transconjugant harboring blaCTX-M-71 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1112,,5183124,CHEMBL1654471,Antimicrobial activity against Klebsiella pneumoniae AH24-270 expressing blaCTX-M-71 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,512.0
1113,,5183127,CHEMBL1654474,Antimicrobial activity against Escherichia coli DH5[alpha] harboring pBC-CTX-M-71 plasmid by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1114,,5183129,CHEMBL1654475,Antimicrobial activity against Escherichia coli DH5[alpha] harboring pBC-CTX-M-15 plasmid by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1115,,5185474,CHEMBL1664999,Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC50,ug ml-1,UO_0000274,128.0
1116,,5185475,CHEMBL1664999,Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC90,ug ml-1,UO_0000274,128.0
1117,,5185476,CHEMBL1664999,Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,1.0
1118,,5185525,CHEMBL1665000,Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC50,ug ml-1,UO_0000274,128.0
1119,,5185526,CHEMBL1665000,Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC90,ug.mL-1,256.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC90,ug ml-1,UO_0000274,256.0
1120,,5185527,CHEMBL1665000,Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC,ug ml-1,UO_0000274,64.0
1121,,5185553,CHEMBL1665003,Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni NCTC 11168 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,32.0
1122,,5185565,CHEMBL1665004,Antibacterial activity against Campylobacter jejuni isolate P270 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1123,,5185577,CHEMBL1665005,Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P835 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1124,,5185590,CHEMBL1665006,Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P850 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1125,,5185603,CHEMBL1665007,Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1962 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1126,,5185616,CHEMBL1665008,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P285 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1127,,5185629,CHEMBL1665009,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P286 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1128,,5185642,CHEMBL1665010,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P305 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1129,,5185655,CHEMBL1665011,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P316 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,64.0
1130,,5185668,CHEMBL1665012,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P338 by NCCLS agar doubling dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC,ug ml-1,UO_0000274,128.0
1131,,5212126,CHEMBL1678645,Antibacterial activity against 10'7 CFU/ml wild-type Listeria monocytogenes EGD-e Serovar 1/2a at 30 ug after 16 hrs by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Millimeter,1332649,=,1,1,=,IZ,mm,21.1,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IZ,mm,UO_0000016,21.1
1132,,5212131,CHEMBL1678842,Antibacterial activity against 10'7 CFU/ml telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a at 30 ug after 16 hrs by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Millimeter,1332649,=,1,1,=,IZ,mm,24.4,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IZ,mm,UO_0000016,24.4
1133,,5212137,CHEMBL1678847,Antibacterial activity against 10'5 CFU/ml wild-type Listeria monocytogenes EGD-e Serovar 1/2a after 16 hrs by by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332649,=,1,1,=,MIC,ug.mL-1,2.87,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,2.87
1134,,5212142,CHEMBL1678849,Antibacterial activity against 10'5 CFU/ml telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a after 16 hrs by by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332649,=,1,1,=,MIC,ug.mL-1,1.44,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,1.44
1135,,5212146,CHEMBL1678850,Ratio of MIC wild-type Listeria monocytogenes EGD-e Serovar 1/2a to MIC for telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1332649,>,1,0,>,FC,,2.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,FC,,,2.0
1136,,5213064,CHEMBL1677043,Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,36.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,36.1
1137,,5213147,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
1138,,5213155,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,4.0
1139,,5213156,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
1140,,5213157,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
1141,,5213174,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,8.0
1142,,5213177,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,8.0
1143,,5213179,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,8.0
1144,,5213181,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,8.0
1145,,5213300,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
1146,,5213302,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
1147,,5213305,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
1148,,5213310,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
1149,,5213313,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
1150,,5213316,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
1151,,5213320,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
1152,,5213323,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
1153,,5213345,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
1154,,5213346,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
1155,,5213361,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
1156,,5213363,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
1157,,5213366,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
1158,,5213369,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
1159,,5214441,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
1160,,5214442,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
1161,,5214443,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
1162,,5214456,CHEMBL1677044,Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
1163,,5214467,CHEMBL1677045,Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,9.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,9.6
1164,,5214478,CHEMBL1677046,Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,9.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,9.6
1165,,5214490,CHEMBL1677047,Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,95.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,95.2
1166,,5214502,CHEMBL1677048,Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,47.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,47.5
1167,,5214514,CHEMBL1677049,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
1168,,5214526,CHEMBL1677050,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
1169,,5214538,CHEMBL1677051,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
1170,,5214569,CHEMBL1677175,Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,91.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,91.4
1171,,5214570,CHEMBL1677176,Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
1172,,5214571,CHEMBL1677179,Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,96.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,96.4
1173,,5214572,CHEMBL1677177,Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,96.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,96.8
1174,,5214573,CHEMBL1677178,Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,Activity,%,20.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,20.7
1175,,5228663,CHEMBL1676213,Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1332508,=,1,0,=,FC,,2.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,FC,,,2.0
1176,,5228677,CHEMBL1676214,Antimicrobial activity against Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332508,=,1,1,=,MIC,ug.mL-1,2.87,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,2.87
1177,,5228678,CHEMBL1676215,Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332508,=,1,1,=,MIC,ug.mL-1,1.44,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,1.44
1178,,5228713,CHEMBL1678230,Antimicrobial activity against Listeria monocytogenes EGD-e at 30 ug after 16 hrs by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Millimeter,1332508,=,1,1,=,IZ,mm,21.3,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IZ,mm,UO_0000016,21.3
1179,,5228714,CHEMBL1676212,Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e at 30 ug after 16 hrs by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Millimeter,1332508,=,1,1,=,IZ,mm,24.8,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IZ,mm,UO_0000016,24.8
1180,,5229403,CHEMBL1679887,Antimicrobial activity against Escherichia coli MC4100 harboring a weak promoter in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1181,,5229404,CHEMBL1679888,Antimicrobial activity against Escherichia coli MC4100 harboring strong promoter in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1182,,5229405,CHEMBL1679889,Antimicrobial activity against Escherichia coli MC4100 harboring promoter hybrid 1 in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1183,,5229406,CHEMBL1679890,Antimicrobial activity against Escherichia coli MC4100 harboring promoter hybrid 2 in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1184,,5229407,CHEMBL1679891,Antimicrobial activity against Escherichia coli MC4100 harboring weak promoter and active promoter P2 in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,96.0
1185,,5229408,CHEMBL1679892,Antimicrobial activity against Escherichia coli MC4100 harboring strong promoter and active promoter P2 in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1186,,5229409,CHEMBL1679893,Antimicrobial activity against Escherichia coli MC4100 harboring promoter hybrid 1 and active promoter P2 in beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1187,,5229410,CHEMBL1679894,Antimicrobial activity against Escherichia coli MC4100 expressing promoterless beta-lactamase GES-1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1188,,5298424,CHEMBL1697380,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 beta-lactamase by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1189,,5298425,CHEMBL1697379,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 A64W mutant beta-lactamase by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1190,,5298426,CHEMBL1697378,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 W87F mutant beta-lactamase by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1191,,5298427,CHEMBL1697377,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 W87A mutant beta-lactamase by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1192,,5298428,CHEMBL1697375,Antimicrobial activity against Escherichia coli XL1-Blue harboring pBC-SK plasmid by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1193,,5298491,CHEMBL1697376,Activity of Escherichia coli XL1-Blue wild-type VIM-2 beta-lactamase by spectrophotometer,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat,/s,8.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat,/s,,8.0
1194,,5298492,CHEMBL1697374,Activity of Escherichia coli XL1-Blue VIM-2 A64W mutant beta-lactamase by spectrophotometer,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat,/s,15.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,15.0
1195,,5298493,CHEMBL1697373,Activity of Escherichia coli XL1-Blue wild-type IMP-1 beta-lactamase by spectrophotometer,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat,/s,8.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,8.0
1196,,5298494,CHEMBL1697371,Ratio of Kcat to Km for Escherichia coli XL1-Blue wild-type VIM-2 beta-lactamase by spectrophotometer,B,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat/Km,uM/hr,0.4,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat/Km,uM/hr,,0.4
1197,,5298495,CHEMBL1697234,Ratio of Kcat to Km for Escherichia coli XL1-Blue VIM-2 A64W mutant beta-lactamase by spectrophotometer,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat/Km,uM/hr,3.7,CHEMBL612545,,Unchecked,,,Kcat/Km,uM/hr,,3.7
1198,,5298496,CHEMBL1697370,Ratio of Kcat to Km for Escherichia coli XL1-Blue wild-type IMP-1 beta-lactamase by spectrophotometer,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat/Km,uM/hr,0.22,CHEMBL612545,,Unchecked,,,Kcat/Km,uM/hr,,0.22
1199,,5298534,CHEMBL1697376,Activity of Escherichia coli XL1-Blue wild-type VIM-2 beta-lactamase by spectrophotometer,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,Km,nM,20000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Km,uM,UO_0000065,20.0
1200,,5298542,CHEMBL1697374,Activity of Escherichia coli XL1-Blue VIM-2 A64W mutant beta-lactamase by spectrophotometer,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,Km,nM,4000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,4.0
1201,,5298551,CHEMBL1697373,Activity of Escherichia coli XL1-Blue wild-type IMP-1 beta-lactamase by spectrophotometer,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,Km,nM,37000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,37.0
1202,,5299312,CHEMBL1697232,Activity of Escherichia coli BL21(DE3) wild-type VIM-2 beta-lactamase by spectrophotometer,B,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat,/s,8.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat,/s,,8.0
1203,,5299313,CHEMBL1697231,Activity of Escherichia coli BL21(DE3) VIM-2 W87F mutant beta-lactamase by spectrophotometer,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,1,,1337786,=,1,0,=,Kcat,/s,12.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat,/s,,12.0
1204,,5299314,CHEMBL1697230,Activity of Escherichia coli BL21(DE3) VIM-2 W87A mutant beta-lactamase by spectrophotometer,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat,/s,15.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat,/s,,15.0
1205,,5299315,CHEMBL1697229,Ratio of Kcat to Km for Escherichia coli BL21(DE3) wild-type VIM-2 beta-lactamase by spectrophotometer,B,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat/Km,/uM/s,0.4,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat/Km,/uM/s,,0.4
1206,,5299316,CHEMBL1696603,Ratio of Kcat to Km for Escherichia coli BL21(DE3) VIM-2 W87F mutant beta-lactamase by spectrophotometer,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat/Km,/uM/s,0.67,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat/Km,/uM/s,,0.67
1207,,5299317,CHEMBL1696602,Ratio of Kcat to Km for Escherichia coli BL21(DE3) VIM-2 W87A mutant beta-lactamase by spectrophotometer,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1337786,=,1,0,=,Kcat/Km,/uM/s,0.65,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Kcat/Km,/uM/s,,0.65
1208,,5299354,CHEMBL1697232,Activity of Escherichia coli BL21(DE3) wild-type VIM-2 beta-lactamase by spectrophotometer,B,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,Km,nM,20000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Km,uM,UO_0000065,20.0
1209,,5299355,CHEMBL1697231,Activity of Escherichia coli BL21(DE3) VIM-2 W87F mutant beta-lactamase by spectrophotometer,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,Km,nM,18000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Km,uM,UO_0000065,18.0
1210,,5299356,CHEMBL1697230,Activity of Escherichia coli BL21(DE3) VIM-2 W87A mutant beta-lactamase by spectrophotometer,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,Km,nM,23000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,Km,uM,UO_0000065,23.0
1211,,5301723,CHEMBL1696767,Antimicrobial activity against Yersinia enterocolitica Biovar 1B 8081 after 20 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC,ug ml-1,UO_0000274,0.75
1212,,5301731,CHEMBL1696768,Antimicrobial activity against beta-lactamase A-deficient Yersinia enterocolitica GY5717 after 20 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC,ug ml-1,UO_0000274,0.5
1213,,5301739,CHEMBL1696769,Antimicrobial activity against beta-lactamase B-deficient Yersinia enterocolitica GY5542 after 20 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC,ug ml-1,UO_0000274,0.75
1214,,5301747,CHEMBL1696770,Antimicrobial activity against beta-lactamase A and B-deficient Yersinia enterocolitica GY5718 after 20 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC,ug ml-1,UO_0000274,0.5
1215,,5302155,CHEMBL1693515,Antimicrobial activity against Escherichia coli DH5alpha carrying Pseudomonas aeruginosa strain PS 297 IMP-18-pLBII after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338480,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
1216,,5302171,CHEMBL1693516,Antimicrobial activity against Escherichia coli DH5alpha carrying Pseudomonas aeruginosa strain PS 297 IMP-1-pLBII after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338480,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1217,,5302187,CHEMBL1693517,Antimicrobial activity against Escherichia coli DH5alpha carrying empty pBC-SK after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338480,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1218,,5302204,CHEMBL1693518,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1338480,=,1,0,=,Kcat,/s,0.9,CHEMBL612545,,Unchecked,,,Kcat,/s,,0.9
1219,,5302220,CHEMBL1693518,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1338480,=,1,1,=,Km,nM,7000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,7.0
1220,,5302236,CHEMBL1693519,Ratio of Kcat to Km for Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1338480,=,1,0,=,Kcat/Km,10'5/M/s,1.3,CHEMBL612545,,Unchecked,,,Kcat/Km,10'5/M/s,,1.3
1221,,5302249,CHEMBL1693520,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1338480,=,1,0,=,Kcat,/s,8.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,8.0
1222,,5302978,CHEMBL1693520,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1338480,=,1,1,=,Km,nM,37000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,37.0
1223,,5302994,CHEMBL1693521,Ratio of Kcat to Km for Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1338480,=,1,0,=,Kcat/Km,10'5/M/s,2.2,CHEMBL612545,,Unchecked,,,Kcat/Km,10'5/M/s,,2.2
1224,,5311393,CHEMBL1694463,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
1225,,5311394,CHEMBL1694464,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
1226,,5311395,CHEMBL1695785,Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,Activity,%,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,1.1
1227,,5311396,CHEMBL1695786,Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
1228,,5312662,CHEMBL1696915,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli ECB2 plasmid carrying CMY-2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1229,,5312670,CHEMBL1697057,Antimicrobial activity against Escherichia coli TOP10 transformed with Enterobacter asburiae CIP 105006 plasmid carrying ACT-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1230,,5312678,CHEMBL1697056,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli DH10B plasmid carrying DHA-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1231,,5312686,CHEMBL1697055,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli pGLK-1 plasmid carrying FOX-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1232,,5312694,CHEMBL1697054,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli ECB-1 plasmid carrying ACC-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1233,,5312702,CHEMBL1697053,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli EC-6 plasmid carrying AmpC-B2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1234,,5312710,CHEMBL1697052,Antimicrobial activity against Escherichia coli TOP10 transformed by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1235,,5312718,CHEMBL1696925,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli ECB2 plasmid carrying CMY-2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1236,,5312726,CHEMBL1696921,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Enterobacter asburiae CIP 105006 plasmid carrying ACT-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1237,,5312734,CHEMBL1696920,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli DH10B plasmid carrying DHA-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1238,,5312742,CHEMBL1696919,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli pGLK-1 plasmid carrying FOX-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1239,,5312750,CHEMBL1696918,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli ECB-1 plasmid carrying ACC-1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
1240,,5312758,CHEMBL1696917,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli EC-6 plasmid carrying AmpC-B2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
1241,,5312766,CHEMBL1696916,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1242,,7964816,CHEMBL1931392,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 25923 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.49
1243,,7964827,CHEMBL1931393,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 6538 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.98
1244,,7964838,CHEMBL1931394,Antibacterial activity against drug-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,MIC,ug.mL-1,0.24,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.24
1245,,7964849,CHEMBL1931395,Antibacterial activity against drug-sensitive Bacillus subtilis ATCC 6633 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,MIC,ug.mL-1,15.63,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,15.63
1246,,7964860,CHEMBL1931396,Antibacterial activity against drug-sensitive Bacillus cereus ATCC 10876 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,MIC,ug.mL-1,31.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,31.25
1247,,7964871,CHEMBL1929939,Antibacterial activity against drug-sensitive Micrococcus luteus ATCC 10240 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.98
1248,Not Determined,7964956,CHEMBL1931392,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 25923 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1564526,,1,0,,MBC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,,,
1249,Not Determined,7964967,CHEMBL1931393,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 6538 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1564526,,1,0,,MBC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,,,
1250,Not Determined,7964978,CHEMBL1931394,Antibacterial activity against drug-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1564526,,1,0,,MBC,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,,,
1251,Not Determined,7964989,CHEMBL1931395,Antibacterial activity against drug-sensitive Bacillus subtilis ATCC 6633 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1564526,,1,0,,MBC,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,,,
1252,Not Determined,7965000,CHEMBL1931396,Antibacterial activity against drug-sensitive Bacillus cereus ATCC 10876 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1564526,,1,0,,MBC,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MBC,,,
1253,Not Determined,7965011,CHEMBL1929939,Antibacterial activity against drug-sensitive Micrococcus luteus ATCC 10240 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL1926593,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1564526,,1,0,,MBC,,,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,,,
1254,,10833767,CHEMBL2014391,Antibacterial activity against Haemophilus influenzae ATCC 49766 after 20 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2010707,Bioorg Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1631723,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
1255,,10861695,CHEMBL2026301,Ratio of MIC for wild type Escherichia coli JC7623 to MIC for acrAB-deficient Escherichia coli JZM120,F,BAO_0000193,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2021919,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1639286,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
1256,,10861714,CHEMBL2026302,Ratio of MIC for wild type Escherichia coli TG1 to MIC for acrB-deficient Escherichia coli KAM3 by two-fold serial dilution method,F,BAO_0000193,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2021919,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1639286,=,1,0,=,Ratio,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,8.0
1257,,10861765,CHEMBL2026305,Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2021919,Eur J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1639286,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.56
1258,inhibitor [Ki>3uM],10996758,CHEMBL2076201,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in SKPT cells,F,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2074537,Eur J Pharm Biopharm,2005.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1670923,>,18,1,>,Ki,nM,3000.0,CHEMBL3325,Rattus norvegicus,"Oligopeptide transporter, kidney isoform",10116.0,,Ki,uM,UO_0000065,3.0
1259,inhibitor [Ki=12.6mM],11000387,CHEMBL2076201,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in SKPT cells,F,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2074537,Eur J Pharm Biopharm,2005.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,1670931,=,18,1,=,Ki,nM,12600000.0,CHEMBL3325,Rattus norvegicus,"Oligopeptide transporter, kidney isoform",10116.0,,Ki,mM,UO_0000065,12.6
1260,,12088183,CHEMBL2167529,Antibacterial activity against Haemophilus influenzae ATCC 49766 incubated for 20 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL2163228,J Med Chem,2012.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1736809,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
1261,Not Determined,12605848,CHEMBL3070138,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MBC,,,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,,,
1262,,12605867,CHEMBL3070138,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.98
1263,Not Determined,12605886,CHEMBL3070139,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MBC,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MBC,,,
1264,,12605905,CHEMBL3070139,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,MIC,ug.mL-1,31.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,31.25
1265,Not Determined,12607263,CHEMBL3070140,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MBC,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,,,
1266,,12607282,CHEMBL3070140,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,MIC,ug.mL-1,15.63,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,15.63
1267,Not Determined,12607301,CHEMBL3070141,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MBC,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,,,
1268,,12607320,CHEMBL3070141,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,MIC,ug.mL-1,0.24,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.24
1269,Not Determined,12607339,CHEMBL3070142,Antibacterial activity against Staphylococcus aureus 14001 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MBC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,,,
1270,Not Determined,12607358,CHEMBL3070142,Antibacterial activity against Staphylococcus aureus 14001 assessed as growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
1271,Not Determined,12607377,CHEMBL3070552,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1839077,,1,0,,MBC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,,,
1272,,12607396,CHEMBL3070552,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044979,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.49
1273,,12611345,CHEMBL3070117,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044844,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.49
1274,,12611357,CHEMBL3070118,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044844,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,62.5
1275,,12611369,CHEMBL3070119,Antibacterial activity against Bacillus subtilis subsp. spizizenii ATCC 6633 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044844,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.49
1276,,12611381,CHEMBL3070120,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044844,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,MIC,ug.mL-1,0.24,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.24
1277,,12611393,CHEMBL3070121,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044844,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,MIC,ug.mL-1,1.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.95
1278,,12611405,CHEMBL3070122,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3044844,Med Chem Res,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,MIC,ug.mL-1,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.49
1279,,13948437,CHEMBL3131967,Efflux ratio of permeability in pig LLC-PK1 cells transfected with human MDR1 at 1 uM by LC-MS/MS analysis,A,BAO_0000193,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3124885,J Med Chem,2014.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1973058,=,1,0,=,Ratio,,2.0,CHEMBL614577,Sus scrofa,LLC-PK1,9823.0,,Ratio,,,2.0
1280,,13948439,CHEMBL3131969,Apparent permeability from apical to basolateral side in pig LLC-PK1 cells by LC-MS/MS analysis,A,BAO_0002808,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3124885,J Med Chem,2014.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,1973058,<,1,0,<,Papp,ucm/s,2.0,CHEMBL614577,Sus scrofa,LLC-PK1,9823.0,,Papp,ucm/s,,2.0
1281,Not Active,14543571,CHEMBL3225251,Induction of membrane associated proteins mislocalization in Bacillus subtilis subsp. subtilis str. 168 assessed as reduction in GFP-MinD protein localization by fluorescence assay,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3217646,Medchemcomm,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,2075007,,1,0,,Activity,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Activity,,,
1282,Not Active,14543591,CHEMBL3225260,Increase in bacterial membrane permeability in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 30 mins post dye addition by propidium iodide dye based flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3217646,Medchemcomm,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,2075007,,1,0,,Activity,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Activity,,,
1283,,14543604,CHEMBL3225263,Induction of transmembrane potential loss in Bacillus subtilis subsp. subtilis str. 168 assessed as lambda575/lambda530 fluorescence emission intensity ratio at 1 times MIC pre-treated for 20 mins and measured 15 mins post dye addition by DiOC2 dye based flow cytometry (Rvb = 0.257 +/- 0.003 no unit),F,BAO_0000193,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3217646,Medchemcomm,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,2075007,=,1,0,=,Ratio,,0.306,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Ratio,,,0.306
1284,,14543606,CHEMBL3225264,Antimicrobial activity against Bacillus subtilis subsp. subtilis str. 168 after 18 hrs by macro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3217646,Medchemcomm,2013.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,2075007,=,1,1,=,MIC,nM,20000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,20.0
1285,,15041078,CHEMBL3365482,Antimicrobial activity against Haemophilus influenzae ATCC 49766 after 20 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3351521,Bioorg Med Chem,2014.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2273814,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
1286,,15711328,CHEMBL3614411,Antimicrobial activity against Staphylococcus citreus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3612037,Eur J Med Chem,2015.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498859,=,1,1,=,MIC,ug.mL-1,600.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,mg/ml,UO_0000274,0.6
1287,,15711337,CHEMBL3614852,Antimicrobial activity against Aeromonas hydrophila by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3612037,Eur J Med Chem,2015.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498859,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,MIC,mg/ml,UO_0000274,0.5
1288,,15711341,CHEMBL3614853,Antimicrobial activity against Escherichia coli by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL3612037,Eur J Med Chem,2015.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498859,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/ml,UO_0000274,0.5
1289,,18323142,CHEMBL4134860,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1290,,18323154,CHEMBL4134861,Antibacterial activity against linezolid and methicillin-resistant Staphylococcus aureus SAU-1 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
1291,,18323166,CHEMBL4134862,Antibacterial activity against methicillin-resistant Staphylococcus aureus 44674 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
1292,,18323178,CHEMBL4134863,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 69856 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
1293,,18323190,CHEMBL4134864,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 39249 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1294,,18323202,CHEMBL4134865,Antibacterial activity against linezolid and methicillin-resistant Staphylococcus hominis alpha26 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,8.0
1295,,18323214,CHEMBL4134866,Antibacterial activity against linezolid and methicillin-resistant Staphylococcus epidermidis G1027 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
1296,,18323226,CHEMBL4134867,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis 3226 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
1297,,18323238,CHEMBL4134868,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,128.0
1298,,18323250,CHEMBL4134869,Antibacterial activity against linezolid and methicillin-resistant Enterococcus faecalis 4150 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,128.0
1299,,18323262,CHEMBL4134870,Antibacterial activity against linezolid and vancomycin-resistant Enterococcus faecium VRE2 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4130476,Eur J Med Chem,2017.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
1300,,18949660,CHEMBL4330708,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2490 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
1301,,18949666,CHEMBL4330709,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 254 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1024.0
1302,,18949672,CHEMBL4330710,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 231 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1024.0
1303,,18949678,CHEMBL4330711,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 417 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1024.0
1304,,18949684,CHEMBL4330712,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1344 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1305,,18949690,CHEMBL4330713,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2901 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1306,,18949696,CHEMBL4330714,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3589 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
1307,,18949702,CHEMBL4330715,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 256 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1308,,18949708,CHEMBL4330716,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3332 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
1309,,18949714,CHEMBL4330717,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3411 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1024.0
1310,,18949720,CHEMBL4330718,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1136 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
1311,,18949726,CHEMBL4330719,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2895 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
1312,,18949732,CHEMBL4330720,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2516 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
1313,,18949738,CHEMBL4330721,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3267 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1314,,18949744,CHEMBL4330722,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 757 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
1315,,18949750,CHEMBL4330723,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1749 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1316,,18949756,CHEMBL4330724,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1402 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1317,,18949762,CHEMBL4330725,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2919 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1318,,18949768,CHEMBL4330726,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2728 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1319,,18949774,CHEMBL4330727,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1717 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1320,,18949780,CHEMBL4330728,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2224 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
1321,,18949786,CHEMBL4330729,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 358 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1322,,18949792,CHEMBL4330730,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3580 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1024.0
1323,,18949798,CHEMBL4330731,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 774 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1024.0
1324,,18949804,CHEMBL4330732,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 200 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1325,,18949810,CHEMBL4330733,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2973 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
1326,,18949816,CHEMBL4330734,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 85 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
1327,,18949822,CHEMBL4330735,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1449 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1328,Not Active,18950107,CHEMBL4330698,"Antibacterial activity against multidrug-resistant Staphylococcus aureus ATCC 43300 infected in BALB/C mouse assessed as mouse survival at 50 mg/kg, ip bid measured after 5 days",F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,3161239,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1329,,18950109,CHEMBL4330696,"Antibacterial activity against multidrug-resistant Staphylococcus aureus ATCC 43300 infected in BALB/C mouse assessed as mouse survival at 25 mg/kg, ip bid measured on day 4 post infection (Rvb = 50%)",F,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4330069,Eur J Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,3161239,=,1,0,=,Activity,%,70.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,70.0
1330,Active,19280842,CHEMBL4409128,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-44 at 128 to 256 ug/ml after 18 hrs by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4406847,Bioorg Med Chem,2019.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,3219778,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1331,,19955517,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4495564,,2020.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,3341935,=,52,1,=,Inhibition,%,3.14,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,3.14
1332,,20147805,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4495565,,2020.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,3359807,=,52,1,=,Inhibition,%,0.18,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.18
1333,Active,20668379,CHEMBL4620142,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as induction of changes in mass spectral profile of bacteria 1 times MIC uM by MALDI-TOF MS analysis,F,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4619716,J Med Chem,2020.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,,3480298,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
1334,,22071297,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4495565,,2020.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://qudt.org/vocab/unit#Percent,3359807,=,52,1,=,Inhibition,%,0.18,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.18
1335,No. Measurements = 1,22086808,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4651402,,2021.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3493175,>,57,1,>,IC50,nM,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,IC50,M,UO_0000065,2e-05
1336,No. Measurements = 1,22086809,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL4651402,,2021.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3493175,<,57,1,>,IC50,nM,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,pIC50,,UO_0000065,4.7
1337,,24415001,CHEMBL5047086,Antimicrobial activity against Klebsiella pneumoniae clinical isolate T2301 expressing NDM-1 assessed as inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5046233,Eur J Med Chem,2022.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783387,=,1,1,=,MIC,ug.mL-1,8.192,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug/L,UO_0000274,8192.0
1338,,24415009,CHEMBL5047087,Antimicrobial activity against Escherichia coli clinical isolate T2228 expressing VIM-1 assessed as inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5046233,Eur J Med Chem,2022.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783387,=,1,1,=,MIC,ug.mL-1,1.024,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug/L,UO_0000274,1024.0
1339,,24996144,CHEMBL5231788,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5230129,Eur J Med Chem,2020.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909494,=,1,1,=,MIC,ug.mL-1,98.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,98.0
1340,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120836,CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,AC50,nM,30000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,AC50,uM,UO_0000065,30.0
1341,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130835,CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,AC50,nM,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,30.0
1342,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174631,CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,AC50,nM,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,AC50,uM,UO_0000065,30.0
1343,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232432,CHEMBL5291747,Antagonist activity at rat Ar in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,AC50,nM,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,30.0
1344,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232986,CHEMBL5291746,Agonist activity at rat Ar in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1436,CEFUROXIME,CHEMBL1436,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,AC50,nM,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,30.0
1345,,1829028,CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,IC50,ug.mL-1,400.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,ug ml-1,UO_0000274,400.0
1346,,1829029,CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,IC50,ug.mL-1,400.0,CHEMBL612582,,Osteoblast,,,IC50,ug ml-1,UO_0000274,400.0
1347,,1833685,CHEMBL856444,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,625855,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1348,,1833686,CHEMBL855426,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,625855,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1349,,1847480,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.25
1350,,1847488,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,0.5
1351,,1847496,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,MBC50,ug ml-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MBC50,ug ml-1,UO_0000274,0.5
1352,,1847504,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MBC90,ug ml-1,UO_0000274,1.0
1353,,1847516,CHEMBL919668,Increase in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,632003,=,1,0,=,Activity,%,13.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,13.0
1354,,1847524,CHEMBL919669,Decrease in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,632003,=,1,0,=,Activity,%,7.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,7.0
1355,,1847537,CHEMBL919653,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL856 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1356,,1847545,CHEMBL919654,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2394 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1357,,1847553,CHEMBL919655,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2414 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1358,,1847561,CHEMBL919656,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2492 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1359,,1847569,CHEMBL919657,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2526 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1360,,1847577,CHEMBL919658,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2554 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1361,,1847585,CHEMBL919659,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2588 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1362,,1847593,CHEMBL919660,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2622 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,BBC,ug ml-1,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,2.0
1363,,1847601,CHEMBL919661,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2639 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,BBC,ug ml-1,4.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,4.0
1364,,1847609,CHEMBL919662,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2640 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1365,,1847617,CHEMBL919663,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2664 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,BBC,ug ml-1,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,8.0
1366,,1847625,CHEMBL919664,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5204 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,BBC,ug ml-1,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,1.0
1367,,1847633,CHEMBL919665,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5254 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1368,,1847641,CHEMBL919666,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5256 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1369,,1847649,CHEMBL919667,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5258 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
1370,,1847657,CHEMBL919110,Effect on biofilm formation of Staphylococcus lugdunensis assessed as percent non-biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,632003,=,1,0,=,Activity,%,80.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,80.0
1371,Not Active,1917552,CHEMBL894357,Antibacterial activity against multidrug resistant Staphylococcus aureus 49589,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1148734,J Med Chem,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,654119,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1372,,1970808,CHEMBL896705,Antibacterial activity against Staphylococcus aureus by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1149559,Bioorg Med Chem Lett,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Millimeter,658475,=,1,1,=,IZ,mm,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,30.0
1373,,1970816,CHEMBL896706,Antibacterial activity against methicillin-resistant Staphylococcus aureus CMAH 0430 by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1149559,Bioorg Med Chem Lett,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Millimeter,658475,=,1,1,=,IZ,mm,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,2.0
1374,,2126284,CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
1375,,2126285,CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
1376,,2126306,CHEMBL934998,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
1377,,2126324,CHEMBL934999,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
1378,,2126358,CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
1379,,2126359,CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
1380,,2126382,CHEMBL935001,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
1381,,2126400,CHEMBL935002,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
1382,,2307358,CHEMBL995399,Antimicrobial activity against Aeromonas caviae A324R expressing metallo-beta-lactamase IMP-19 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,MIC,ug ml-1,UO_0000274,1024.0
1383,,2307368,CHEMBL995396,Antimicrobial activity against Escherichia coli DH5alpha expressing pJDB2 containing Aeromonas caviae A324R metallo-beta-lactamase gene by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1384,,2307378,CHEMBL995400,Antimicrobial activity against Escherichia coli DH5alpha expressing pIP19 containing Aeromonas caviae A324R metallo-beta-lactamase blaIMP-19 gene by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1385,,2307388,CHEMBL995401,Antimicrobial activity against Escherichia coli DH5alpha by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1386,,2494966,CHEMBL982494,Sensitivity of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 30 ug/disk after 20 hrs,F,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Millimeter,779194,>=,1,1,>=,IZ,mm,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,18.0
1387,,2494970,CHEMBL982497,Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 30 ug/disk after 20 hrs,F,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Millimeter,779194,<=,1,1,<=,IZ,mm,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,14.0
1388,,2494974,CHEMBL982497,Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 30 ug/disk after 20 hrs,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,779194,=,1,0,=,Activity,%,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.0
1389,,2575055,CHEMBL983705,Antimicrobial activity against Chryseobacterium indologenes NF16 isolate assessed as drug level at which microbial resistance was observed by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742747,=,1,0,=,Activity,ug ml-1,64.0,CHEMBL613343,Chryseobacterium indologenes,Chryseobacterium indologenes,253.0,,Activity,ug ml-1,UO_0000274,64.0
1390,,2575063,CHEMBL983707,Antimicrobial activity against Escherichia coli HB101 harboring pBC-IND-5 plasmid containing metallo-beta-lactamase IND5 assessed as drug level at which microbial resistance was observed by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742747,=,1,0,=,Activity,ug ml-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,64.0
1391,,2575067,CHEMBL983706,Antimicrobial activity against Escherichia coli HB101 harboring pBC-SK plasmid assessed as drug level at which microbial resistance was observed by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742747,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,1.0
1392,,2575080,CHEMBL983708,Activity of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis,B,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,742747,=,1,1,=,Km,nM,25000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,25.0
1393,,2575085,CHEMBL983708,Activity of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis,B,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,742747,=,1,0,=,Kcat,/s,0.46,CHEMBL612545,,Unchecked,,,Kcat,/s,,0.46
1394,,2575095,CHEMBL983709,Ratio of Kcat to Km of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis,B,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,742747,=,1,0,=,Kcat/Km,/uM/s,0.018,CHEMBL612545,,Unchecked,,,Kcat/Km,/uM/s,,0.018
1395,,2575106,CHEMBL983710,Ratio of Kcat to Km of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis relative to control,B,BAO_0001103,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,742747,=,1,0,=,Activity,%,2.1,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,2.1
1396,,2661612,CHEMBL1035450,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 in peritoneal dialysis fluid administered as bolus dose 2 hrs after infection measured after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818119,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
1397,,2661613,CHEMBL1035451,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 in peritoneal dialysis fluid administered as bolus dose 2 hrs after infection measured after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818119,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1398,,2727618,CHEMBL1051154,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM551 harboring active lytH and llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,200.0
1399,,2727619,CHEMBL1051155,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM563 harboring active lytH gene and inactive llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
1400,,2727620,CHEMBL1051156,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SR-17164 harboring inactive lytH gene and active llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,400.0
1401,,2727621,CHEMBL1055077,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1832 harboring inactive lytH and inactive llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,200.0
1402,,2727622,CHEMBL1055078,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1648 harboring inactive lytH gene and active llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,400.0
1403,,2727623,CHEMBL1055079,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1816 harboring inactive lytH and inactive llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
1404,,2727624,CHEMBL1055080,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1663 harboring inactive lytH gene and active llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,400.0
1405,,2727625,CHEMBL1055081,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1825 harboring inactive lytH and inactive llm gene after 24 hrs by serial twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,200.0
1406,,2990734,CHEMBL1043580,Fraction unbound in human plasma,A,BAO_0000179,BAO_0000366,cell-free format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1156824,J Med Chem,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,861681,=,1,1,=,Fu,,0.18,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,Fu,,,0.18
1407,,3385749,CHEMBL1221131,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus OC 4172 assessed as inhibition of growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929471,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
1408,,3385750,CHEMBL1221132,Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 assessed as inhibition of growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929471,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1409,Not Determined,3385751,CHEMBL1221133,Antimicrobial activity against Pseudomonas aeruginosa OC 4351 assessed as inhibition of growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,,1,0,,MIC,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,,,
1410,Not Determined,3385752,CHEMBL1221134,Antimicrobial activity against Pseudomonas aeruginosa OC 4354 assessed as inhibition of growth by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,,1,0,,MIC,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,,,
1411,,3385837,CHEMBL1218872,"fT>MIC in Staphylococcus aureus Smith OC 4172 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,fT>MIC,hr,2.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,hr,UO_0000032,2.4
1412,,3385838,CHEMBL1218873,"fT>MIC in Staphylococcus aureus OC 8525 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,fT>MIC,hr,0.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,hr,UO_0000032,0.3
1413,,3385839,CHEMBL1218876,fT>MIC in Staphylococcus aureus OC 4172 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,fT>MIC,%,10.2,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,%,UO_0000187,10.2
1414,,3385840,CHEMBL1218877,fT>MIC in Staphylococcus aureus OC 8525 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,fT>MIC,%,1.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,%,UO_0000187,1.3
1415,,3385843,CHEMBL1218874,"fT>MIC in Pseudomonas aeruginosa OC 4351 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,fT>MIC,hr,1.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,hr,UO_0000032,1.5
1416,,3385844,CHEMBL1218875,"fT>MIC in Pseudomonas aeruginosa OC 4354 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,fT>MIC,hr,0.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,hr,UO_0000032,0.8
1417,,3385845,CHEMBL1218878,fT>MIC in Pseudomonas aeruginosa OC 4351 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,fT>MIC,%,6.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,%,UO_0000187,6.4
1418,,3385846,CHEMBL1218879,fT>MIC in Pseudomonas aeruginosa OC 4354 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,fT>MIC,%,3.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,%,UO_0000187,3.3
1419,,3385880,CHEMBL1218848,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 1.6 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,1090.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,1090.0
1420,,3385881,CHEMBL1218849,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 6.2 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,987.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,987.0
1421,,3385882,CHEMBL1218850,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 25 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,877.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,877.0
1422,,3385883,CHEMBL1218851,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 100 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,781.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,781.0
1423,,3385884,CHEMBL1218852,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 1.6 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,1383.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,1383.0
1424,,3385885,CHEMBL1218853,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 6.2 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,1300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,1300.0
1425,,3385886,CHEMBL1218854,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 25 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,1070.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,1070.0
1426,,3385887,CHEMBL1218855,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 100 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,929471,=,1,0,=,Activity,mm3,912.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mm3,,912.0
1427,,3473945,CHEMBL1262275,Activity of Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB101,B,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,960634,=,1,0,=,Kcat,/s,0.56,CHEMBL612545,,Unchecked,,,Kcat,/s,,0.56
1428,,3477664,CHEMBL1262218,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolates isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,1.0
1429,,3477676,CHEMBL1262218,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolates isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,2.0
1430,,3477702,CHEMBL1262872,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU18 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,16.0
1431,,3477703,CHEMBL1262211,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU28 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,32.0
1432,,3477704,CHEMBL1262212,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU33 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,1.0
1433,,3477705,CHEMBL1262213,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU47 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,4.0
1434,,3477706,CHEMBL1262214,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU57 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,16.0
1435,,3477707,CHEMBL1262215,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU67 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,128.0
1436,,3477708,CHEMBL1262216,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU69 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,128.0
1437,,3477709,CHEMBL1262217,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU90 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,64.0
1438,,3478632,CHEMBL1266063,"Antibacterial activity against Klebsiella pneumoniae isolate VA367 with blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, blaSHV-12, aac(6')-1b genes by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
1439,,3478652,CHEMBL1266065,"Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA367 containing blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, aac(6')-1b genes by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
1440,,3478667,CHEMBL1266067,"Antibacterial activity against Klebsiella pneumoniae isolate VA375 with blaKPC-3, qnrA1, blaTEM-1, blaSHV-11 genes by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
1441,,3478682,CHEMBL1266069,"Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA375 containing qnrA1, blaTEM-1, blaSHV-11genes by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
1442,,3478697,CHEMBL1266200,Antibacterial activity against Escherichia coli J53 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,<=,1,1,<=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1443,,3489647,CHEMBL1265728,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1,B,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,961251,=,1,0,=,Kcat,/s,0.55,CHEMBL612545,,Unchecked,,,Kcat,/s,,0.55
1444,,3489648,CHEMBL1265732,Ratio of Kcat Km for Aeromonas enteropelogenes Beta-lactamase TRU1,B,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,961251,=,1,0,=,Kcat/Km,10'3/M/s,4.6,CHEMBL612545,,Unchecked,,,Kcat/Km,10'3/M/s,,4.6
1445,,3489759,CHEMBL1265728,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1,B,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,961251,=,1,1,=,Km,nM,120000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,120.0
1446,,3489766,CHEMBL1265735,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1 assessed as steady state compound hydrolysis rate,B,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,961251,=,1,0,=,Kcat,/s,0.25,CHEMBL612545,,Unchecked,,,Kcat,/s,,0.25
1447,,3489767,CHEMBL1265735,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1 assessed as steady state compound hydrolysis rate,B,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,961251,=,1,1,=,Km,nM,80000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,80.0
1448,,3489768,CHEMBL1265736,Ratio of Kcat Km for Aeromonas enteropelogenes Beta-lactamase TRU1 assessed as steady state compound hydrolysis rate,B,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,961251,=,1,0,=,Kcat/Km,10'3/M/s,3.1,CHEMBL612545,,Unchecked,,,Kcat/Km,10'3/M/s,,3.1
1449,,3495397,CHEMBL1262269,Antimicrobial activity against Serratia marcescens isolate CT-118 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,64.0
1450,,3495398,CHEMBL1262270,Antimicrobial activity against Escherichia coli HB101 expressing recombinant plasmid encoded TEM-149 by broth macrodilution method,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1451,,3495399,CHEMBL1262271,Antimicrobial activity against Escherichia coli HB101 harboring empty vector pBK-SK by broth macrodilution method,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1452,,3495400,CHEMBL1262272,Antimicrobial activity against Escherichia coli HB101 expressing plasmid encoded TEM-149 T182M mutant by broth macrodilution method,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1453,,3495401,CHEMBL1262273,Activity of Beta-lactamase TEM-149 expressed in Escherichia coli HB101,B,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,960634,=,1,1,=,Km,nM,68000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,68.0
1454,,3495402,CHEMBL1262274,Ratio of Kcat to Km for Beta-lactamase TEM-149 expressed in Escherichia coli HB101,B,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,960634,=,1,0,=,Kcat/Km,/uM/s,0.032,CHEMBL612545,,Unchecked,,,Kcat/Km,/uM/s,,0.032
1455,,3495403,CHEMBL1262275,Activity of Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB101,B,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,960634,=,1,1,=,Km,nM,35000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,35.0
1456,,3495404,CHEMBL1262276,Ratio of Kcat to Km for Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB101,B,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,960634,=,1,0,=,Kcat/Km,/uM/s,0.016,CHEMBL612545,,Unchecked,,,Kcat/Km,/uM/s,,0.016
1457,,3495405,CHEMBL1262277,Activity of Beta-lactamase TEM-10,B,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,960634,=,1,1,=,Km,nM,417000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,417.0
1458,,3495406,CHEMBL1262278,Ratio of Kcat to Km for Beta-lactamase TEM-10,B,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,960634,=,1,0,=,Kcat/Km,/uM/s,0.03,CHEMBL612545,,Unchecked,,,Kcat/Km,/uM/s,,0.03
1459,,3495407,CHEMBL1262279,Antimicrobial activity against Enterobacter aerogenes isolate SS-13 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,64.0
1460,,3495408,CHEMBL1262273,Activity of Beta-lactamase TEM-149 expressed in Escherichia coli HB101,B,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,960634,=,1,0,=,Kcat,/s,2.2,CHEMBL612545,,Unchecked,,,Kcat,/s,,2.2
1461,,3495409,CHEMBL1262277,Activity of Beta-lactamase TEM-10,B,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,960634,=,1,0,=,Kcat,/s,12.5,CHEMBL612545,,Unchecked,,,Kcat,/s,,12.5
1462,,3534763,CHEMBL1286720,Antimicrobial activity against beta-lactamase CTX-M-15-producing fluoroquinolone-resistant Escherichia coli FMV5825 expressing qnrB2 and aac(6')-Ib-cr and harboring gyrA Ser83Ile and Asp87Asn mutant gene and ParC Ser80Ile and Glu84Val mutant gene obtained from dog with urinary tract infection by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970680,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1463,,3534785,CHEMBL1286723,Antimicrobial activity against Azide-resistant Escherichia coli J53 transconjugant harboring Escherichia coli DH5alpha-5825 qnrB2 gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970680,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1464,,3534807,CHEMBL1286726,Antimicrobial activity against Azide-resistant Escherichia coli J53 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970680,<=,1,1,<=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1465,,3566525,CHEMBL1278288,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1466,,3566526,CHEMBL1278287,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1467,,3566527,CHEMBL1278286,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1468,,3566528,CHEMBL1278285,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1469,,3566529,CHEMBL1278284,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1470,,3566530,CHEMBL1279494,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1471,,3566531,CHEMBL1279493,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1472,,3566532,CHEMBL1279492,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1473,,3566533,CHEMBL1279256,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1474,,3566534,CHEMBL1279255,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1475,,3567119,CHEMBL1278283,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1476,,3567120,CHEMBL1278282,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1477,,3567121,CHEMBL1278281,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1478,,3567122,CHEMBL1278280,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1479,,3567123,CHEMBL1278279,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1480,,3567124,CHEMBL1279254,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
1481,,3567125,CHEMBL1279253,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
1482,,3567126,CHEMBL1279252,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
1483,,3567127,CHEMBL1279251,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
1484,Not Determined,3567178,CHEMBL1279250,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
1485,Not Determined,3567179,CHEMBL1279248,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
1486,Not Determined,3567180,CHEMBL1279247,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
1487,Not Determined,3567181,CHEMBL1279246,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
1488,Not Determined,3567182,CHEMBL1279244,Antimicrobial activity against vancomycin-resistant Enterococcus sp. assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,,,
1489,Not Determined,3567183,CHEMBL1279245,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,,,
1490,Not Determined,3567184,CHEMBL1279243,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,,,
1491,Not Determined,3567185,CHEMBL1279242,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,,,
1492,Not Determined,3567186,CHEMBL1279241,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,,,
1493,,3567677,CHEMBL1279226,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,4.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,4.9
1494,,3567680,CHEMBL1279230,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,6.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,6.2
1495,,3567684,CHEMBL1279229,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,7.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,7.7
1496,,3567685,CHEMBL1279227,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,7.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,7.7
1497,,3567686,CHEMBL1279228,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,7.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,7.8
1498,,3567688,CHEMBL1279237,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,8.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,8.6
1499,,3567692,CHEMBL1279236,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,11.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,11.5
1500,,3567703,CHEMBL1279240,Antimicrobial activity against CTX-M ESBL producing Escherichia coli assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,20.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,20.1
1501,,3567710,CHEMBL1279239,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,21.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,21.9
1502,,3567719,CHEMBL1279238,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,25.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,25.8
1503,,3567724,CHEMBL1279185,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,83.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,83.3
1504,,3567725,CHEMBL1278289,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,88.9,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,88.9
1505,,3567726,CHEMBL1279225,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,89.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,89.7
1506,,3567727,CHEMBL1279183,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,94.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,94.1
1507,,3567728,CHEMBL1279184,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,Activity,%,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,100.0
1508,Not Determined,3567729,CHEMBL1279235,Antimicrobial activity against ESBL producing Klebsiella pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,,,
1509,Not Determined,3567730,CHEMBL1279234,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,,,
1510,Not Determined,3567731,CHEMBL1279233,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,,,
1511,Not Determined,3567732,CHEMBL1279232,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,,,
1512,Not Determined,3567733,CHEMBL1279231,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,,,
1513,Not Determined,3567734,CHEMBL1278290,Antimicrobial activity against Haemophilus influenzae assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
1514,Not Determined,3567735,CHEMBL1278291,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
1515,Not Determined,3567736,CHEMBL1278293,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
1516,Not Determined,3567737,CHEMBL1278294,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969581,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
1517,,3568125,CHEMBL1278618,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
1518,,3568134,CHEMBL1278617,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
1519,,3568143,CHEMBL1278619,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC 12403 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
1520,,3568152,CHEMBL1278620,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B1 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,2.0
1521,,3568161,CHEMBL1278621,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B6 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1522,,3568170,CHEMBL1278622,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B7 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
1523,,3568179,CHEMBL1278623,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B8 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1524,,3568188,CHEMBL1278624,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B10 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1525,,3568197,CHEMBL1278625,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B12 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1526,,3568206,CHEMBL1278626,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B40 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1527,,3568215,CHEMBL1278627,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B60 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1528,,3568224,CHEMBL1278628,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B68 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
1529,,3568233,CHEMBL1278629,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B502 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
1530,,3568242,CHEMBL1278630,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B503 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
1531,,3568251,CHEMBL1278631,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B513 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1532,,3568260,CHEMBL1278632,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B514 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,1.0
1533,,3568269,CHEMBL1279013,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B516 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
1534,,3568278,CHEMBL1279014,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 harboring PBP-2X Q557E mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,2.0
1535,,3568287,CHEMBL1279051,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 harboring PBP-2X V405A mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
1536,,3571902,CHEMBL1279616,Antimicrobial activity against Escherichia coli DH5alpha by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1537,,3571903,CHEMBL1279617,Antimicrobial activity against Escherichia coli DH5alpha harboring plasmid containing OXA-58-3 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1538,Not Determined,3571904,CHEMBL1279618,Antimicrobial activity against Escherichia coli DH5alpha harboring plasmid containing OXA-58-4 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969633,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
1539,,3571905,CHEMBL1279619,Antimicrobial activity against Acinetobacter baumannii TVICU53 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
1540,,3571906,CHEMBL1279620,Antimicrobial activity against Acinetobacter baumannii Ab290 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
1541,,3571907,CHEMBL1279621,Antimicrobial activity against Acinetobacter baumannii Ab290 harboring TVICU53 plasmid by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
1542,,3571908,CHEMBL1279622,Antimicrobial activity against Acinetobacter baumannii Ab290 containing plasmid harboring OXA-58-3 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
1543,Not Determined,3571909,CHEMBL1279623,Antimicrobial activity against Acinetobacter baumannii Ab290 containing plasmid harboring OXA-58-4 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,969633,,1,0,,MIC,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,,,
1544,,3571910,CHEMBL1279624,Antimicrobial activity against Acinetobacter baumannii ATCC 15151T by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
1545,,3571911,CHEMBL1279625,Antimicrobial activity against Acinetobacter baumannii ATCC 15151T containing plasmid harboring OXA-58-3 by broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
1546,,3572199,CHEMBL1280784,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 3047-05 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1547,,3572200,CHEMBL1280785,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 5662-05 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1548,,3572201,CHEMBL1280786,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 6649-05 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1549,,3572202,CHEMBL1280787,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 7490-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1550,,3572203,CHEMBL1280788,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 9012-04 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1551,,3572204,CHEMBL1280789,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IB isolate 5436-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,1.0
1552,,3572205,CHEMBL1280790,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype II isolate 3776-04 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1553,,3572206,CHEMBL1280791,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype II isolate 9051-04 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1554,,3572207,CHEMBL1280792,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 3444-99 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1555,,3572208,CHEMBL1280793,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 7037-99 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1556,,3572209,CHEMBL1280794,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 3789-04 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,1.0
1557,,3572210,CHEMBL1280795,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 6138-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1558,,3572211,CHEMBL1280796,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 7507-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1559,,3572212,CHEMBL1280797,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1560,,3572213,CHEMBL1280798,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IV isolate 3454-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1561,,3572214,CHEMBL1280799,Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 4214-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1562,,3572215,CHEMBL1280800,Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 6149-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1563,,3572216,CHEMBL1280801,Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 7368-04 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1564,,3572217,CHEMBL1280802,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 3386-05 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.12
1565,,3572218,CHEMBL1280803,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 4857-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.5
1566,,3572219,CHEMBL1280804,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 5677-04 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,1.0
1567,,3572220,CHEMBL1280805,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 9171-03 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
1568,,3572221,CHEMBL1280806,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and harboring empty vector by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,16.0
1569,,3572222,CHEMBL1280807,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and harboring plasmid expressing wild-type pbp2x by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,2.0
1570,,3572223,CHEMBL1280808,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607 expressing multiple copies of wild-type pbp2x by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,2.0
1571,Active,4376504,CHEMBL1614174,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1163177,=,7,1,=,Potency,nM,44668.4,CHEMBL1293248,Bacillus subtilis,4'-phosphopantetheinyl transferase ffp,1423.0,,Potency,um,UO_0000065,44.6684
1572,Inconclusive,4599204,CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1163177,=,7,1,=,Potency,nM,17740.7,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,Potency,um,UO_0000065,17.7407
1573,,5079593,CHEMBL1614682,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,Vdss,L.kg-1,0.11,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,0.11
1574,,5079611,CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310941,=,1,1,=,Vdss,L.kg-1,0.12,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,0.12
1575,,5079642,CHEMBL1614680,Volume of distribution at steady state in monkey after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,Vdss,L.kg-1,0.13,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,0.13
1576,,5079766,CHEMBL1614672,Fraction unbound in human after iv administration,A,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310941,=,1,1,=,Fu,,0.18,CHEMBL3879801,,NON-PROTEIN TARGET,,,fu,,,0.18
1577,,5079865,CHEMBL1614676,Volume of distribution at steady state in rat after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,0,=,Vdss,mL/min/kg,0.23,CHEMBL612558,,ADMET,,,Vdss,mL/min/kg,,0.23
1578,,5080085,CHEMBL1614678,Volume of distribution at steady state in dog after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,Vdss,L.kg-1,0.27,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,0.27
1579,,5080780,CHEMBL1614681,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,CL,mL.min-1.kg-1,0.88,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,0.88
1580,,5080786,CHEMBL1614671,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310941,=,1,1,=,CL,mL.min-1.kg-1,0.89,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,0.89
1581,,5081359,CHEMBL1614674,Half life in human after iv administration,A,BAO_0002115,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Hour,1310941,=,1,1,=,T1/2,hr,1.7,CHEMBL612558,,ADMET,,,t1/2,h,UO_0000032,1.7
1582,,5081459,CHEMBL1614679,Clearance in monkey after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,CL,mL.min-1.kg-1,1.9,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,1.9
1583,,5082033,CHEMBL1614677,Clearance in dog after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,CL,mL.min-1.kg-1,3.5,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,3.5
1584,,5082568,CHEMBL1614675,Clearance in rat after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1310942,=,1,1,=,CL,mL.min-1.kg-1,6.7,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,6.7
1585,,5086045,CHEMBL1633249,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313913,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,32.0
1586,,5086054,CHEMBL1633250,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as susceptible isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1313913,=,1,0,=,Activity,%,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,0.0
1587,,5086063,CHEMBL1633251,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1313913,=,1,0,=,Activity,%,235.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,235.0
1588,,5086072,CHEMBL1633249,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313913,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
1589,,5087897,CHEMBL1633673,Antimicrobial activity against Shigella sonnei UIH-1 expressing beta-lactamase CTX-M-64 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,16.0
1590,,5087898,CHEMBL1633677,Antimicrobial activity against rifampicin-resistant Escherichia coli X1037 transconjugant by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1591,,5087899,CHEMBL1633788,Antimicrobial activity against rifampicin-resistant Escherichia coli X1037 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1592,,5087900,CHEMBL1633792,Antimicrobial activity against Escherichia coli XL-1 Blue transconjugant harboring beta-lactamase CTX-M-64 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1593,,5087901,CHEMBL1633796,Antimicrobial activity against Escherichia coli XL-1 Blue harboring plasmid CL1920 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1594,,5096427,CHEMBL1635103,Ratio of drug level in patient bone with bone and joint infection to MIC90 for drug-susceptible Staphylococci,F,BAO_0000193,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1315469,=,1,0,=,Ratio,,5.0,CHEMBL345,,Nucleic Acid,,,Ratio,,,5.0
1595,,5096432,CHEMBL1635097,"Drug level in patient bone with bone and joint infection measured per gram of tissue at 60 to 80 mg/kg/day, iv administered as continuous infusion for 42 days measured on day 7 by agar disk diffusion assay",A,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1315469,=,1,0,=,Drug uptake,ug,13.5,CHEMBL612558,,ADMET,,,Drug uptake,ug,UO_0000023,13.5
1596,,5096433,CHEMBL1635098,"Ratio of drug level in bone to serum in patient with bone and joint infection at 60 to 80 mg/kg/day, iv administered as continuous infusion for 42 days",A,BAO_0000193,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1315469,=,1,0,=,Ratio,,0.25,CHEMBL612558,,ADMET,,,Ratio,,,0.25
1597,,5096434,CHEMBL1635102,Ratio of drug level in patient serum with bone and joint infection to MIC90 for drug-susceptible Staphylococci,F,BAO_0000193,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1315469,=,1,0,=,Ratio,,60.75,CHEMBL345,,Nucleic Acid,,,Ratio,,,60.75
1598,,5096435,CHEMBL1635099,Antimicrobial activity against methicillin-susceptible Staphylococcus,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315469,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,mg/L,UO_0000274,1.0
1599,,5096436,CHEMBL1635100,Antimicrobial activity against Streptococcus,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315469,=,1,1,=,MIC90,ug.mL-1,0.1,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC90,mg/L,UO_0000274,0.1
1600,,5099543,CHEMBL1641042,Antimicrobial activity against Escherichia coli harboring plasmid pPCRScript by Etest,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1601,,5099558,CHEMBL1641040,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-18 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1602,,5099562,CHEMBL1640892,Antimicrobial activity against Pseudomonas aeruginosa isolate 243-31C expressing beta-lactamase VIM-18 isolated from sputum of patient by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
1603,,5099568,CHEMBL1641041,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-2 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
1604,,5099601,CHEMBL1641044,Ratio of MIC for Escherichia coli harboring beta-lactamase VIM-2 to MIC for Escherichia coli harboring beta-lactamase VIM-18,F,BAO_0000193,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1313021,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
1605,,5144969,CHEMBL1665423,Bactericidal activity against yafQ gene-deficient Escherichia coli K-12 BW25113 biofilm assessed as log reduction of viable cells after 24 hrs relative to wild-type Escherichia coli K-12 BW25113,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1326412,=,1,0,=,FC,,2400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2400.0
1606,Not Active,5144973,CHEMBL1665426,Bactericidal activity against Escherichia coli K-12 BW25113 biofilm harboring pCA24N ptac::yafQ plasmid assessed as log reduction of viable cells after 24 hrs pretreated with 5 uM of IPTG for 4 hrs,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1326412,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
1607,,5144975,CHEMBL1665425,Effect on survival of Escherichia coli K-12 BW25113 biofilm harboring pCA24N ptac::yafQ plasmid assessed as increase in cell survival after 24 hrs pretreated with 5 uM of IPTG for 4 hrs relative to wild-type Escherichia coli K-12 BW25114,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1326412,=,1,0,=,FC,,10000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,10000.0
1608,,5144979,CHEMBL1665427,Antimicrobial activity against Escherichia coli K-12 BW25113 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326412,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1609,,5144983,CHEMBL1665428,Antimicrobial activity against yafQ gene-deficient Escherichia coli K-12 BW25113 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326412,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1610,Active,5144987,CHEMBL1665430,Bactericidal activity against Escherichia coli K-12 BW25113 stationary-phase planktonic cell assessed as log reduction of viable cells after 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1326412,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
1611,Active,5144988,CHEMBL1665429,Bactericidal activity against yafQ gene-deficient Escherichia coli K-12 BW25113 stationary-phase planktonic cell assessed as log reduction of viable cells after 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1326412,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
1612,,5153316,CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326465,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.063
1613,,5153330,CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326465,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.125
1614,,5153344,CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326465,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,0.25
1615,,5182551,CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
1616,,5182557,CHEMBL1653406,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1617,,5182563,CHEMBL1653407,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1618,,5182569,CHEMBL1653408,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1619,,5182576,CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,64.0
1620,,5182582,CHEMBL1653410,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1621,,5182588,CHEMBL1653411,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1622,,5182594,CHEMBL1653412,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1623,,5182601,CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,1.0
1624,,5182607,CHEMBL1653414,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
1625,,5182613,CHEMBL1653415,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1626,,5182619,CHEMBL1653416,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1627,,5182626,CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,64.0
1628,,5182632,CHEMBL1653418,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1629,,5182638,CHEMBL1653419,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
1630,,5182644,CHEMBL1653420,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
1631,,5182675,CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,32.0
1632,,5182690,CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC50,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,128.0
1633,,5182705,CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,2.0
1634,,5182709,CHEMBL1653443,Antibacterial activity against Escherichia coli assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,82.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,82.1
1635,,5182713,CHEMBL1653445,Antibacterial activity against Escherichia coli assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,3.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,3.8
1636,,5182717,CHEMBL1653447,Antibacterial activity against Escherichia coli assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,14.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,14.1
1637,,5182722,CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,2.0
1638,,5182727,CHEMBL1653451,Antibacterial activity against Klebsiella pneumoniae assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,91.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,91.4
1639,,5182732,CHEMBL1653453,Antibacterial activity against Klebsiella pneumoniae assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,1.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,1.8
1640,,5182737,CHEMBL1653578,Antibacterial activity against Klebsiella pneumoniae assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,6.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,6.8
1641,,5182743,CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC50,ug ml-1,UO_0000274,8.0
1642,,5182748,CHEMBL1653582,Antibacterial activity against Klebsiella oxytoca assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,60.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,60.0
1643,,5182753,CHEMBL1654229,Antibacterial activity against Klebsiella oxytoca assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,23.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,23.0
1644,,5182758,CHEMBL1654231,Antibacterial activity against Klebsiella oxytoca assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,17.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,17.0
1645,,5182764,CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,128.0
1646,,5182769,CHEMBL1654235,Antibacterial activity against Enterobacter cloacae assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,5.4,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,5.4
1647,,5182774,CHEMBL1654237,Antibacterial activity against Enterobacter cloacae assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,3.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,3.6
1648,,5182779,CHEMBL1654239,Antibacterial activity against Enterobacter cloacae assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,91.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,91.0
1649,,5182785,CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,8.0
1650,,5182790,CHEMBL1654243,Antibacterial activity against Proteus mirabilis assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,86.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,86.6
1651,,5182795,CHEMBL1654245,Antibacterial activity against Proteus mirabilis assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,8.4,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,8.4
1652,,5182800,CHEMBL1654366,Antibacterial activity against Proteus mirabilis assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,5.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,5.0
1653,,5182806,CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC50,ug.mL-1,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,128.0
1654,,5182811,CHEMBL1654370,Antibacterial activity against Serratia marcescens assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.9,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,0.9
1655,,5182816,CHEMBL1654372,Antibacterial activity against Serratia marcescens assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,0.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,0.0
1656,,5182821,CHEMBL1654374,Antibacterial activity against Serratia marcescens assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,Activity,%,99.1,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,99.1
1657,,5182827,CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC50,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,128.0
1658,,5182845,CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC50,ug.mL-1,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,128.0
1659,,5182851,CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC50,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,128.0
1660,,5182874,CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
1661,,5182881,CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,128.0
1662,,5182888,CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,4.0
1663,,5183944,CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,128.0
1664,,5183963,CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,128.0
1665,,5183969,CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,128.0
1666,,5183975,CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,64.0
1667,,5183980,CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,8.0
1668,,5183986,CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,32.0
1669,,5183992,CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,128.0
1670,,5183998,CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,16.0
1671,,5184004,CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,128.0
1672,,5184010,CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,128.0
1673,,5184016,CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,128.0
1674,,5184022,CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,128.0
1675,,5184032,CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
1676,,5184039,CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
1677,,5184046,CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
1678,,5184053,CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
1679,,5184072,CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
1680,,5184078,CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
1681,,5184084,CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
1682,,5184089,CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
1683,,5184095,CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.5
1684,,5184101,CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,1.0
1685,,5184107,CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,1.0
1686,,5184113,CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,2.0
1687,,5184119,CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
1688,,5184125,CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,128.0
1689,,5184131,CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,64.0
1690,,5185365,CHEMBL1653792,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
1691,,5185366,CHEMBL1653792,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
1692,,5185367,CHEMBL1653792,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
1693,,5185368,CHEMBL1653793,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
1694,,5185369,CHEMBL1653793,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
1695,,5185370,CHEMBL1653793,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,64.0
1696,,5185371,CHEMBL1653794,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
1697,,5185372,CHEMBL1653794,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
1698,,5185373,CHEMBL1653794,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
1699,,5185374,CHEMBL1653795,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.8
1700,,5185375,CHEMBL1653795,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,2.0
1701,,5185376,CHEMBL1653795,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
1702,,5185377,CHEMBL1653796,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
1703,,5185378,CHEMBL1653796,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
1704,,5185379,CHEMBL1653796,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
1705,,5185380,CHEMBL1653797,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
1706,,5185381,CHEMBL1653797,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
1707,,5185382,CHEMBL1653797,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
1708,,5185383,CHEMBL1653798,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.6
1709,,5185384,CHEMBL1653798,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
1710,,5185385,CHEMBL1653798,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
1711,,5185386,CHEMBL1653799,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
1712,,5185387,CHEMBL1653799,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
1713,,5185388,CHEMBL1653799,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
1714,,5185389,CHEMBL1653800,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
1715,,5185390,CHEMBL1653801,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1716,,5185391,CHEMBL1653802,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1717,,5185392,CHEMBL1653803,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1718,,5185393,CHEMBL1653804,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1719,,5185394,CHEMBL1653805,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1720,,5185395,CHEMBL1653806,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1721,,5185396,CHEMBL1653807,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1722,,5185397,CHEMBL1653808,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,89.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,89.0
1723,,5185398,CHEMBL1653904,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.0
1724,,5185399,CHEMBL1653905,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,6.0
1725,,5185400,CHEMBL1653906,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1726,,5185401,CHEMBL1653907,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1727,,5185402,CHEMBL1653908,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1728,,5185403,CHEMBL1653909,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1729,,5185404,CHEMBL1653910,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1730,,5185405,CHEMBL1653911,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,33.0
1731,,5185406,CHEMBL1653912,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,50.0
1732,,5185407,CHEMBL1653913,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,8.0
1733,,5185408,CHEMBL1653914,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,2.0
1734,,5185409,CHEMBL1662193,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,2.0
1735,,5185410,CHEMBL1662194,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,1.0
1736,,5185411,CHEMBL1662195,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,3.0
1737,,5185412,CHEMBL1662196,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
1738,,5185413,CHEMBL1662197,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,23.0
1739,,5185414,CHEMBL1662198,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,12.0
1740,,5185415,CHEMBL1662199,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,20.0
1741,,5185416,CHEMBL1662200,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,24.0
1742,,5185417,CHEMBL1662201,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.0
1743,,5185418,CHEMBL1662202,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,9.0
1744,,5185419,CHEMBL1662203,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,3.0
1745,,5185420,CHEMBL1662204,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,Activity,%,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,2.0
1746,,5185422,CHEMBL1662206,Drug level in bone of methicillin-susceptible Staphylococcus aureus infected human after 60 mins,A,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,0,=,Drug uptake,ug ml-1,6.9,CHEMBL612558,,ADMET,,,Drug uptake,ug ml-1,UO_0000274,6.9
1747,,5311373,CHEMBL1694463,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
1748,,5311374,CHEMBL1694464,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
1749,,5311375,CHEMBL1695785,Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,Activity,%,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,1.1
1750,,5311376,CHEMBL1695786,Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
1751,,5314137,CHEMBL1690796,Antimicrobial activity against methicillin-resistant and tetracycline-sensitive Staphylococcus aureus COLn,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687797,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338137,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1752,,5314138,CHEMBL1690797,"Antimicrobial activity against methicillin-, tetracycline-susceptible and chromosomal mecA deficient Staphylococcus aureus COLnex",F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687797,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338137,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
1753,,5314139,CHEMBL1690798,"Antimicrobial activity against beta-lactam-resistant and chromosomal mecA deficient Staphylococcus aureus CRB harboring PBP4 E183A F241R, GdpP N182K and AcrB I960V mutant genes selected after 21 days of serial passage in ceftobiprole",F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1687797,Antimicrob Agents Chemother,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338137,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1754,drug-induced liver injury reported,5317184,CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1340930,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
1755,drug-induced liver injury reported,5318135,CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1340930,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
1756,no drug-induced liver injury reported,5319086,CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1340930,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
1757,Active,5573085,CHEMBL1613775,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771, AID488772]",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,Potency,nM,11917.3,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,Potency,uM,UO_0000065,11.9173
1758,inconclusive,5777022,CHEMBL1614279,"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,Potency,nM,756.9,CHEMBL5686,Trypanosoma brucei,6-phospho-1-fructokinase,5691.0,,Potency,uM,UO_0000065,0.7569
1759,inconclusive,6786573,CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1360075,,7,1,,Potency,nM,50118.7,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,Potency,uM,UO_0000065,50.1187
1760,inconclusive,6813747,CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,Potency,nM,11917.3,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,Potency,uM,UO_0000065,11.9173
1761,inactive,10406353,CHEMBL1963940,PUBCHEM_BIOASSAY: Biochemical firefly luciferase enzyme assay for NPC. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1163177,,7,1,,Potency,nM,40533.4,CHEMBL5567,Photinus pyralis,Luciferin 4-monooxygenase,7054.0,,Potency,uM,UO_0000065,40.5334
1762,,10861699,CHEMBL2026301,Ratio of MIC for wild type Escherichia coli JC7623 to MIC for acrAB-deficient Escherichia coli JZM120,F,BAO_0000193,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2021919,Eur J Med Chem,2012.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1639290,=,1,0,=,Ratio,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,1.0
1763,,10861734,CHEMBL2026303,Ratio of MIC for wild type Salmonella typhimurium SH5014 to MIC for Salmonella typhimurium SH7616 harboring missense mutation in acrA/acrB gene by two-fold serial dilution method,F,BAO_0000193,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2021919,Eur J Med Chem,2012.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1639290,=,1,0,=,Ratio,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Ratio,,,1.0
1764,,10861769,CHEMBL2026305,Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2021919,Eur J Med Chem,2012.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1639290,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.39
1765,substrate [+],10997426,CHEMBL2076298,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,F,BAO_0000375,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2074125,Drug Metabol Pharmacokin,2002.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1671097,,18,0,,Activity,,,CHEMBL1777665,Rattus norvegicus,Solute carrier family 22 member 6,10116.0,,Activity,,,
1766,inhibitor [13.6 % of control],10999102,CHEMBL2078171,"TP_TRANSPORTER: inhibition of Indoxyl sulfate uptake (Indoxyl sulfate: 2 uM, Cefazolin: 1000 uM) in Xenopus laevis oocytes",F,BAO_0001103,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2074014,J Neurochem,2002.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,1669375,=,18,0,=,Activity,%,13.6,CHEMBL2073666,Rattus norvegicus,Solute carrier family 22 member 8,10116.0,,Activity,%,UO_0000187,13.6
1767,inhibitor [Ki=450uM],11003146,CHEMBL2077063,TP_TRANSPORTER: inhibition of PAH uptake in Xenopus laevis oocytes,F,BAO_0000192,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2074574,J Pharmacol Exp Ther,1999.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1669252,=,18,1,=,Ki,nM,450000.0,CHEMBL1777665,Rattus norvegicus,Solute carrier family 22 member 6,10116.0,,Ki,uM,UO_0000065,450.0
1768,inhibitor [Ki=560uM],11003202,CHEMBL2078130,TP_TRANSPORTER: inhibition of PAH uptake in OAT1-expressing S2 cells,F,BAO_0000192,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2074497,Life Sci,2002.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1669477,=,18,1,=,Ki,nM,560000.0,CHEMBL1777665,Rattus norvegicus,Solute carrier family 22 member 6,10116.0,,Ki,uM,UO_0000065,560.0
1769,inhibitor [Ki=780uM],11003272,CHEMBL2076054,TP_TRANSPORTER: inhibition of Estrone sulfate uptake in OAT3-expressing S2 cells,F,BAO_0000192,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2074497,Life Sci,2002.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1669477,=,18,1,=,Ki,nM,780000.0,CHEMBL2073666,Rattus norvegicus,Solute carrier family 22 member 8,10116.0,,Ki,uM,UO_0000065,780.0
1770,Not Determined,13451217,CHEMBL2429127,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2424578,Med Chem Res,2013.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,1918263,,1,0,,MBC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,,,
1771,,13451239,CHEMBL2429127,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL2424578,Med Chem Res,2013.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1918263,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
1772,inactive,14200134,CHEMBL3215181,PubChem BioAssay. qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,1360075,,7,1,,Potency,nM,35481.3,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,35.4813
1773,,14616142,CHEMBL3255486,Antibacterial activity against penicillin G-resistant Staphylococcus aureus HH 127 after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
1774,,14616163,CHEMBL3255487,Antibacterial activity against Escherichia coli 12140 after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.8
1775,,14616184,CHEMBL3255488,Antibacterial activity against Klebsiella pneumoniae 4200 after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.8
1776,,14616205,CHEMBL3255489,Antibacterial activity against Salmonella paratyphi ATCC 12176 after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.8
1777,,14616226,CHEMBL3255490,Antibacterial activity against Shigella paradysenteriae HH 117 after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,0.4
1778,,14616247,CHEMBL3255491,Antibacterial activity against Enterobacter aerogenes ATCC 13048 after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,1.6
1779,,14616268,CHEMBL3255492,Antibacterial activity against Streptococcus faecalis after overnight incubation by twofold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2091711,>,1,1,>,MIC,ug.mL-1,13.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,13.0
1780,Not Active,14616289,CHEMBL3255493,Antibacterial activity against Pseudomonas aeruginosa after overnight incubation by twofold agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2091711,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
1781,,14618635,CHEMBL3255494,Antibacterial activity against Escherichia coli 12140 infected in sc dosed mouse assessed as mouse survival after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244150,J Med Chem,1977.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2091711,=,1,0,=,PD50,mg kg-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,PD50,mg kg-1,UO_0000308,6.0
1782,,14638005,CHEMBL3258066,Antibacterial activity against Streptococcus pyogenes infected in po dosed CD1 mouse assessed as host survival administered 1 and 4 hrs after infection measured on day 4,F,BAO_0003036,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,=,1,1,=,ED50,mg.kg-1,1.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,ED50,mg kg-1,UO_0000308,1.8
1783,,14640516,CHEMBL3257616,Antibacterial activity against benzylpenicillin-resistant Staphylococcus aureus after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
1784,,14640517,CHEMBL3257617,Antibacterial activity against Staphylococcus aureus after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
1785,,14640518,CHEMBL3257618,Antibacterial activity against Staphylococcus epidermidis after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.8
1786,,14640519,CHEMBL3257619,Antibacterial activity against Staphylococcus faecalis after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,100.0
1787,,14640520,CHEMBL3258043,Antibacterial activity against Streptococcus pneumoniae after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.1
1788,,14640521,CHEMBL3258044,Antibacterial activity against Streptococcus pyogenes after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.1
1789,,14640522,CHEMBL3258045,Antibacterial activity against Enterobacter aerogenes after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,>,1,1,>,MIC,ug.mL-1,50.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,50.0
1790,,14640523,CHEMBL3258046,Antibacterial activity against Enterobacter cloacae after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,50.0
1791,,14640524,CHEMBL3258047,Antibacterial activity against Escherichia coli after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.8
1792,,14640525,CHEMBL3258048,Antibacterial activity against Klebsiella pneumoniae after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.6
1793,,14640526,CHEMBL3258049,Antibacterial activity against Proteus mirabilis after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,6.2,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,6.2
1794,,14640527,CHEMBL3258050,Antibacterial activity against Proteus vulgaris after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,100.0
1795,,14640528,CHEMBL3258051,Antibacterial activity against Providencia stuartii after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,>,1,1,>,MIC,ug.mL-1,50.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC,ug ml-1,UO_0000274,50.0
1796,,14640529,CHEMBL3258052,Antibacterial activity against Pseudomonas aeruginosa after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,100.0
1797,,14640530,CHEMBL3258053,Antibacterial activity against Salmonella schottmuelleri after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,ug ml-1,UO_0000274,1.6
1798,,14640531,CHEMBL3258054,Antibacterial activity against Salmonella marcescens after 17 hrs by serial two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2093322,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,ug ml-1,UO_0000274,100.0
1799,,14640532,CHEMBL3258055,Antibacterial activity against benzylpenicillin-resistant Staphylococcus aureus infected in sc dosed CD1 mouse assessed as host survival administered 1 and 4 hrs after infection measured on day 4,F,BAO_0003036,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,=,1,1,=,ED50,mg.kg-1,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,22.0
1800,,14640533,CHEMBL3258057,Antibacterial activity against Escherichia coli infected in sc dosed CD1 mouse assessed as host survival administered 1 and 4 hrs after infection measured on day 4,F,BAO_0003036,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,=,1,1,=,ED50,mg.kg-1,0.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,0.6
1801,,14640534,CHEMBL3258058,Antibacterial activity against Klebsiella pneumoniae infected in sc dosed CD1 mouse assessed as host survival administered 1 and 4 hrs after infection measured on day 4,F,BAO_0003036,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,=,1,1,=,ED50,mg.kg-1,42.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,ED50,mg kg-1,UO_0000308,42.0
1802,,14640535,CHEMBL3258059,Antibacterial activity against Proteus mirabilis infected in sc dosed CD1 mouse assessed as host survival administered 1 and 4 hrs after infection measured on day 4,F,BAO_0003036,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,=,1,1,=,ED50,mg.kg-1,79.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,ED50,mg kg-1,UO_0000308,79.0
1803,,14640536,CHEMBL3258060,Antibacterial activity against Salmonella schottmuelleri infected in sc dosed CD1 mouse assessed as host survival administered 1 and 4 hrs after infection measured on day 4,F,BAO_0003036,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,=,1,1,=,ED50,mg.kg-1,2.2,CHEMBL614446,Salmonella,Salmonella,590.0,,ED50,mg kg-1,UO_0000308,2.2
1804,Not Active,14640537,CHEMBL3258061,Antibacterial activity against Neisseria gonorrhoeae after 17 hrs by serial two fold dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,,1,0,,Activity,,,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,Activity,,,
1805,Not Active,14640538,CHEMBL3258062,Antibacterial activity against Haemophilus influenzae after 17 hrs by serial two fold dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,,1,0,,Activity,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,,,
1806,Not Active,14640539,CHEMBL3258063,Antibacterial activity against Bacteroides fragilis after 17 hrs by serial two fold dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,,1,0,,Activity,,,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,,,
1807,Not Active,14640540,CHEMBL3258064,Antibacterial activity against Fusobacterium varium after 17 hrs by serial two fold dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,,1,0,,Activity,,,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,Activity,,,
1808,Not Active,14640541,CHEMBL3258065,Antibacterial activity against Clostridium perfringens after 17 hrs by serial two fold dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3244034,J Med Chem,1978.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2093322,,1,0,,Activity,,,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,Activity,,,
1809,,14675742,CHEMBL3283389,Antibacterial activity against penicillin G-resistant Staphylococcus aureus HH 127 by two-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105583,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
1810,,14675769,CHEMBL3283390,Antibacterial activity against Escherichia coli 12140 by two-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105583,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.8
1811,,14675796,CHEMBL3283391,Antibacterial activity against Klebsiella pneumoniae 4200 by two-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105583,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.8
1812,,14675823,CHEMBL3283392,Antibacterial activity against Salmonella paratyphi ATCC 12176 by two-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105583,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.8
1813,,14675849,CHEMBL3283393,Antibacterial activity against Shigella paradysenteriae HH 117 by two-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105583,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,0.4
1814,,14675876,CHEMBL3283394,Antibacterial activity against Enterobacter aerogenes ATCC 13048 by two-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2105583,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,1.6
1815,,14705559,CHEMBL3283395,Antibacterial activity against Escherichia coli 12140 infected in sc dosed mouse assessed as host protection administered at 1 and 5 hrs post-infection,F,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2105583,=,1,0,=,PD50,mg kg-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,PD50,mg kg-1,UO_0000308,6.0
1816,Active,14705586,CHEMBL3283396,Antibacterial activity against Staphylococcus aureus 23390 by two-fold agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3272096,J Med Chem,1976.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2105583,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1817,,15130097,CHEMBL3385113,Antimicrobial activity against Staphylococcus epidermidis ATCC 35984 after 12 to 16 hrs by broth micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3352199,Eur J Med Chem,2014.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2258257,=,1,1,=,MIC,nM,17600.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,17.6
1818,,15134536,CHEMBL3385114,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 12 to 16 hrs by broth micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3352199,Eur J Med Chem,2014.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2258257,=,1,1,=,MIC,nM,17600.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,17.6
1819,,15134556,CHEMBL3385115,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 12 to 16 hrs by broth micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3352199,Eur J Med Chem,2014.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2258257,=,1,1,=,MIC,nM,17600.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,17.6
1820,,15464486,CHEMBL3529963,Total biliary clearance in iv dosed dog,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3526096,Drug Metab Dispos,2013.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2470395,=,1,1,=,CL,mL.min-1.kg-1,0.066,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,CL,ml/min.kg,,0.066
1821,,15464487,CHEMBL3529957,Unbound biliary clearance in iv dosed rat,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3526096,Drug Metab Dispos,2013.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2470395,=,1,1,=,CL,mL.min-1.kg-1,11.24,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,CL free,ml/min.kg,,11.24
1822,,15464518,CHEMBL3529745,Total biliary clearance in iv dosed rat,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3526096,Drug Metab Dispos,2013.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2470395,=,1,1,=,CL,mL.min-1.kg-1,1.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,CL,ml/min.kg,,1.4
1823,,15464640,CHEMBL3529965,Unbound biliary clearance in iv dosed dog,A,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3526096,Drug Metab Dispos,2013.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,2470395,=,1,1,=,CL,mL.min-1.kg-1,0.089,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,CL free,ml/min.kg,,0.089
1824,inactive,15471869,CHEMBL3561973,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2042105,,7,1,,AC50,nM,570.0,CHEMBL612545,,Unchecked,,,AC50,uM,UO_0000065,0.57
1825,inactive,15509752,CHEMBL3562133,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2042105,,7,1,,AC50,nM,22387.2,CHEMBL612545,,Unchecked,,,AC50,uM,UO_0000065,22.3872
1826,inactive,15593857,CHEMBL3562135,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2042105,,7,1,,AC50,nM,354.8,CHEMBL612545,,Unchecked,,,AC50,uM,UO_0000065,0.3548
1827,inactive,15598004,CHEMBL3562136,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ",F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL1201862,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,2042105,,7,1,,AC50,nM,17782.8,CHEMBL612545,,Unchecked,,,AC50,uM,UO_0000065,17.7828
1828,,15623056,CHEMBL3588633,Antibacterial activity against Escherichia coli after 12 hrs by macrodilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3585285,ACS Med Chem Lett,2015.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2484927,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
1829,,16743926,CHEMBL3858080,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate CAN-ICU 61589 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798641,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
1830,,18071441,CHEMBL4015259,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate CAN-ICU 61589 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995424,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
1831,,18071442,CHEMBL4015264,Antibacterial activity against gentamicin-resistant Escherichia coli isolate CAN-ICU 61714 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995424,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1832,,18071443,CHEMBL4015265,Antibacterial activity against amikacin-resistant Escherichia coli isolate CAN-ICU 63074 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995424,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1833,,18335086,CHEMBL4136912,Antibacterial activity in Escherichia coli clinical isolates endogenously expressing NDM1 incubated at 37 degC for 18 hrs by spectrophotometry,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4130619,ACS Med Chem Lett,2018.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3044501,=,1,1,=,MIC,ug.mL-1,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2048.0
1834,,18335090,CHEMBL4136913,Antibacterial activity in Escherichia coli BL21 (DE3) expressing pET-24a-blaNDM-1 incubated at 37 degC for 18 hrs by spectrophotometry,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4130619,ACS Med Chem Lett,2018.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3044501,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1835,,18783199,CHEMBL4270881,Antibiotic activity against methicillin-resistant Staphylococcus aureus isolate CAIRD116 by broth microdilution assay or Alamar blue dye based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4270487,J Nat Prod,2017.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121049,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1836,,18783212,CHEMBL4270882,Antibiotic activity against methicillin-resistant Staphylococcus aureus isolate CAIRD142 by broth microdilution assay or Alamar blue dye based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4270487,J Nat Prod,2017.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121049,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1837,,18783225,CHEMBL4270883,Antibiotic activity against methicillin-resistant Staphylococcus aureus isolate CAIRD148 by broth microdilution assay or Alamar blue dye based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4270487,J Nat Prod,2017.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121049,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
1838,,19000950,CHEMBL4343495,Antimicrobial activity against Bacillus subtilis,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.063
1839,,19000951,CHEMBL4343500,Antimicrobial activity against Proteus vulgaris,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.063
1840,,19000952,CHEMBL4343501,Antimicrobial activity against Salmonella typhimurium,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.063
1841,,19000953,CHEMBL4343558,Antimicrobial activity against Streptococcus pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.063
1842,,19000954,CHEMBL4343559,Antimicrobial activity against Proteus mirabilis,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.063
1843,,19000955,CHEMBL4343560,Antimicrobial activity against Rhodococcus equi,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL612439,Prescottella equi,Prescottella equi,43767.0,,MIC,ug ml-1,UO_0000274,0.063
1844,,19000956,CHEMBL4343561,Antimicrobial activity against Bacillus thuringiensis,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170632,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614959,Bacillus thuringiensis,Bacillus thuringiensis,1428.0,,MIC,ug ml-1,UO_0000274,0.063
1845,Active,19280843,CHEMBL4409128,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-44 at 128 to 256 ug/ml after 18 hrs by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4406847,Bioorg Med Chem,2019.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,,3219777,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1846,,19956672,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4495564,,2020.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,3343090,=,52,1,=,Inhibition,%,-4.6,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,-4.6
1847,,20148829,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4495565,,2020.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,3360962,=,52,1,=,Inhibition,%,0.04,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.04
1848,,22072452,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4495565,,2020.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://qudt.org/vocab/unit#Percent,3360962,=,52,1,=,Inhibition,%,0.04,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.04
1849,No. Measurements = 1,22089212,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4651402,,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3493552,>,57,1,>,IC50,nM,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,IC50,M,UO_0000065,2e-05
1850,No. Measurements = 1,22089213,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4651402,,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3493552,<,57,1,>,IC50,nM,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,pIC50,,UO_0000065,4.7
1851,,22958390,CHEMBL4768214,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4765269,Eur J Med Chem,2020.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565180,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1852,,22958415,CHEMBL4768215,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4765269,Eur J Med Chem,2020.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565180,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1853,,23206713,CHEMBL4821799,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,8132.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8132.0
1854,,23206719,CHEMBL4821800,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4096.0
1855,,23206725,CHEMBL4821801,Antibacterial activity against Escherichia coli 01 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,16000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16000.0
1856,,23206731,CHEMBL4821802,Antibacterial activity against against Escherichia coli 04 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4096.0
1857,,23206737,CHEMBL4821803,Antibacterial activity against against Escherichia coli 06 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4096.0
1858,,23206743,CHEMBL4821804,Antibacterial activity against Escherichia coli 08 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4096.0
1859,,23206749,CHEMBL4821805,Antibacterial activity against against Escherichia coli 24 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4096.0
1860,,23206755,CHEMBL4821806,Antibacterial activity against Klebsiella pneumoniae assessed as reduction in bacterial growth incubated for 24 hrs by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4096.0
1861,,23206761,CHEMBL4821807,Antibacterial activity against Carbapenem-resistant Pseudomonas aeruginosa assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL4819085,Bioorg Med Chem,2021.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3609225,>,1,1,>,MIC,ug.mL-1,16000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16000.0
1862,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120948,CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3940016,>,1,1,>,AC50,nM,30000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,AC50,uM,UO_0000065,30.0
1863,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130149,CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3940016,>,1,1,>,AC50,nM,300000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,300.0
1864,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173943,CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3940016,=,1,1,=,AC50,nM,160000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,AC50,uM,UO_0000065,160.0
1865,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232484,CHEMBL5291747,Antagonist activity at rat Ar in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3940016,>,1,1,>,AC50,nM,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,30.0
1866,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232649,CHEMBL5291746,Agonist activity at rat Ar in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL1435,CEFAZOLIN,CHEMBL1435,0,http://www.openphacts.org/units/Nanomolar,3940016,>,1,1,>,AC50,nM,300000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,300.0
1867,,85487,CHEMBL680694,"Inhibition of [3H]tetracycline uptake into everted membrane vesicles, prepared from tetracycline resistant Escherichia coli D1-209",F,BAO_0000190,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1126586,J Med Chem,1993.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/Nanomolar,235765,=,1,1,=,IC50,nM,2600.0,CHEMBL4785,Escherichia coli K-12,Multidrug translocase mdfA,83333.0,,IC50,uM,UO_0000065,2.6
1868,,669716,CHEMBL676723,In vitro minimum inhibitory concentration against Escherichia coli UBMS 88-1 (tet B efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1869,,669717,CHEMBL676722,In vitro minimum inhibitory concentration against Escherichia coli PRP-1 (tet A efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1870,,669718,CHEMBL677725,In vitro minimum inhibitory concentration against Escherichia coli J3272 (tet C efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
1871,,669719,CHEMBL677726,In vitro minimum inhibitory concentration against Escherichia coli J3272 (tet D efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
1872,,669720,CHEMBL676724,In vitro minimum inhibitory concentration against Escherichia coli UBMS 90-4 (tet M ribosomal protection).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1873,,669721,CHEMBL676725,In vitro minimum inhibitory concentration against Escherichia coli UBMS 90-5 (sensitive).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
1874,,669722,CHEMBL880926,In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 88-7 (tet K efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
1875,,669723,CHEMBL805469,In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 90-1 (tet M ribosomal protection).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
1876,,669724,CHEMBL805470,In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 90-3 (sensitive).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
1877,,669725,CHEMBL805471,In vitro minimum inhibitory concentration against Staphylococcus aureus smith (sensitive).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
1878,,669726,CHEMBL676522,In vitro minimum inhibitory concentration against Enterococcus faecalis ATCC 29212.,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94146,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
1879,,883170,CHEMBL806947,Inhibitory activity against MRSA,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1129675,J Med Chem,1996.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,241421,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
1880,,1113027,CHEMBL858634,Minimum inhibition concentration against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1134864,Bioorg Med Chem Lett,2002.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120334,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.12
1881,,1113028,CHEMBL676759,Minimum inhibition concentration against Enterococcus faecalis,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1134864,Bioorg Med Chem Lett,2002.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120334,<,1,1,<,MIC,ug.mL-1,0.098,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.098
1882,,1113029,CHEMBL813109,Minimum inhibition concentration against Methicillin resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1134864,Bioorg Med Chem Lett,2002.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120334,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
1883,,1252540,CHEMBL679856,In vitro antibacterial activity against Escherichia coli UBMS 88-1 Tet B,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
1884,,1252541,CHEMBL679697,In vitro antibacterial activity against Escherichia coli PRP1 Tet A,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
1885,,1252542,CHEMBL679691,In vitro antibacterial activity against Escherichia coli J3272 Tet C,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
1886,,1252543,CHEMBL679692,In vitro antibacterial activity against Escherichia coli J3272 Tet D,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,4.0
1887,,1252544,CHEMBL679857,In vitro antibacterial activity against Escherichia coli UBMS 90-4 Tet M,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,16.0
1888,,1252545,CHEMBL679859,In vitro antibacterial activity against Escherichia coli UBMS 90-5 sensitive,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,16.0
1889,,1252546,CHEMBL858627,In vitro antibacterial activity against Staphylococcus aureus UBMS 88-7 Tet K,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,16.0
1890,,1252547,CHEMBL810419,In vitro antibacterial activity against Staphylococcus aureus UBMS 90-1 Tet M,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,8.0
1891,,1252548,CHEMBL810420,In vitro antibacterial activity against Staphylococcus aureus UBMS 90-3 sensitive,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,2.0
1892,,1252549,CHEMBL810418,In vitro antibacterial activity against Staphylococcus aureus Smith sensitive,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,2.0
1893,,1252550,CHEMBL674209,In vitro antibacterial activity against Enterococcus ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,53019,=,1,0,=,MIC,ug mg-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug mg-1,,4.0
1894,,1666224,CHEMBL870571,Antibacterial activity against Staphylococcus aureus UBMS 90-1 carrying tetM-resistant determinant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
1895,,1666225,CHEMBL870572,Antibacterial activity against Staphylococcus aureus UBMS 90-2 carrying tetM-resistant determinant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
1896,,1666226,CHEMBL870573,Antibacterial activity against Staphylococcus aureus UBMS 90-3,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
1897,,1666227,CHEMBL870574,Antibacterial activity against Staphylococcus aureus UBMS 88-7 carrying the tetK-resistant determinant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
1898,,1666228,CHEMBL871131,Antibacterial activity against Staphylococcus aureus Smith,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
1899,,1666229,CHEMBL871132,Antibacterial activity against Enterococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
1900,,1666230,CHEMBL871134,Antibacterial activity against Escherichia coli UBMS 88-1 carrying tetB-resistant determinant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
1901,,1666231,CHEMBL871135,Antibacterial activity against Minocycline sensitive Escherichia coli 88-2,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
1902,,1666232,CHEMBL871137,Antibacterial activity against Escherichia coli UBMS 89-1 carrying tetM-resistant determinant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
1903,,1666233,CHEMBL871138,Antibacterial activity against Minocylcine sensitive Escherichia coli 89-2,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147771,Bioorg Med Chem Lett,2006.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,413144,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
1904,,1828455,CHEMBL854623,Antibacterial activity against Enterococcus faecalis isolate 5744,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
1905,,1828463,CHEMBL854624,Antibacterial activity against Enterococcus faecalis isolate 5743,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
1906,,1828472,CHEMBL854625,Antibacterial activity against Enterococcus faecalis isolate 5742,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
1907,,1828480,CHEMBL854626,Antibacterial activity against Enterococcus faecium isolate 2547,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
1908,,1828487,CHEMBL854627,Antibacterial activity against Enterococcus faecium isolate 5749,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
1909,,1828495,CHEMBL854628,Antibacterial activity against Enterococcus faecium isolate 5750,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
1910,,1828503,CHEMBL854629,Antibacterial activity against Enterococcus faecium isolate 5751,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
1911,,1828510,CHEMBL854630,Antibacterial activity against Enterococcus faecium isolate 5752,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
1912,,1828517,CHEMBL854631,Antibacterial activity against Enterococcus faecium isolate 5753,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
1913,,1828524,CHEMBL854632,Antibacterial activity against Enterococcus faecalis isolate 5745,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
1914,,1828531,CHEMBL854633,Antibacterial activity against Enterococcus faecalis isolate 5746,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625689,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.12
1915,,1829565,CHEMBL855263,Antimicrobial activity against methicillin-resistant Staphylococcus aureus embedded in MRD biofilm model at 3 mg/ml after 15 mins,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,324.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,CFU/ml,,,324.0
1916,,1829566,CHEMBL855264,Antimicrobial activity against methicillin-resistant Staphylococcus aureus embedded in MRD biofilm model at 3 mg/ml after 15 mins in drug assessed as 24 hr regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,308.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,CFU/ml,,,308.0
1917,,1829567,CHEMBL855913,Antimicrobial activity against Candida parapsilosis embedded in MRD biofilm at 3 mg/ml after 15 mins,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,138.0,CHEMBL612868,Candida parapsilosis,Candida parapsilosis,5480.0,,CFU/ml,,,138.0
1918,,1829568,CHEMBL855914,Antimicrobial activity against Candida parapsilosis embedded in MRD biofilm at 3 mg/ml after 15 mins in drug assessed as 24 hr regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,500.0,CHEMBL612868,Candida parapsilosis,Candida parapsilosis,5480.0,,CFU/ml,,,500.0
1919,,1829569,CHEMBL855919,Antimicrobial activity against methicillin-resistant Staphylococcus aureus in silicone disk biofilm at 3 mg/ml after 60 mins,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,5000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,CFU/ml,,,5000.0
1920,,1829570,CHEMBL855920,Antimicrobial activity against methicillin-resistant Staphylococcus aureus in silicone disk biofilm at 3 mg/ml after 60 mins in drug assessed as 24 hr regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,5000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,CFU/ml,,,5000.0
1921,,1829571,CHEMBL855925,Antimicrobial activity against Candida parapsilosis in silicone disk biofilm at 3 mg/ml after 60 mins,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,5000.0,CHEMBL612868,Candida parapsilosis,Candida parapsilosis,5480.0,,CFU/ml,,,5000.0
1922,,1829572,CHEMBL855926,Antimicrobial activity against Candida parapsilosis in silicone disk biofilm at 3 mg/ml after 60 mins in drug assessed as 24 hr regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142157,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,625697,=,1,0,=,CFU/ml,,5000.0,CHEMBL612868,Candida parapsilosis,Candida parapsilosis,5480.0,,CFU/ml,,,5000.0
1923,,1832417,CHEMBL911423,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from deployed military patient,F,BAO_0003035,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625559,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1.0
1924,,1832418,CHEMBL911423,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from deployed military patient,F,BAO_0000179,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625559,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,4.0
1925,,1832433,CHEMBL911424,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from nondeployed military patient,F,BAO_0000179,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625559,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,4.0
1926,,1832434,CHEMBL911424,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from nondeployed military patient,F,BAO_0003035,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142062,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625559,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
1927,,1847740,CHEMBL920565,Antimicrobial activity against Burkholderia cepacia complex isolated from cystic fibrosis patient by broth microdilution assay,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142070,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632032,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC50,ug ml-1,UO_0000274,8.0
1928,,1847741,CHEMBL920565,Antimicrobial activity against Burkholderia cepacia complex isolated from cystic fibrosis patient by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142070,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632032,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC90,ug ml-1,UO_0000274,32.0
1929,,1847750,CHEMBL920566,Antimicrobial susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patient assessed as percent susceptible isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142070,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://qudt.org/vocab/unit#Percent,632032,=,1,0,=,Activity,%,38.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,Activity,%,UO_0000187,38.0
1930,,1847756,CHEMBL920567,Antimicrobial susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patient assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142070,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://qudt.org/vocab/unit#Percent,632032,=,1,0,=,Activity,%,37.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,Activity,%,UO_0000187,37.0
1931,,1848136,CHEMBL916441,Antimicrobial activity against Nocardia cyriacigeorgica after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL4296583,Nocardia cyriacigeorgica,Nocardia cyriacigeorgica,135487.0,,MIC,ug/L,UO_0000274,0.06
1932,,1848144,CHEMBL916442,Antimicrobial activity against Nocardia farcinica after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,MIC,ug/L,UO_0000274,1.0
1933,,1848152,CHEMBL916443,Antimicrobial activity against Nocardia otitidiscaviarum after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL613233,Nocardia otitidiscaviarum,Nocardia otitidiscaviarum,1823.0,,MIC,ug/L,UO_0000274,0.5
1934,,1848160,CHEMBL916444,Antimicrobial activity against Nocardia abscessus after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.06
1935,,1848168,CHEMBL916445,Antimicrobial activity against Nocardia beijingensis after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.06
1936,,1848176,CHEMBL916446,Antimicrobial activity against Nocardia nova after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL612977,Nocardia nova,Nocardia nova,37330.0,,MIC,ug/L,UO_0000274,1.0
1937,,1848185,CHEMBL916447,Antimicrobial activity against Nocardia veterana after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
1938,,1848193,CHEMBL916448,Antimicrobial activity against Nocardia transvalensis after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL613234,Nocardia transvalensis,Nocardia transvalensis,37333.0,,MIC,ug/L,UO_0000274,1.0
1939,,1848201,CHEMBL916449,Antimicrobial activity against Nocardia carnea after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL4296582,Nocardia carnea,Nocardia carnea,37328.0,,MIC,ug/L,UO_0000274,0.5
1940,,1848209,CHEMBL916450,Antimicrobial activity against Nocardia brasiliensis after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC,ug/L,UO_0000274,1.0
1941,,1848216,CHEMBL916451,Antimicrobial activity against Nocardia sp. after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632096,=,1,1,=,MIC,ug.mL-1,0.00025,CHEMBL612979,Nocardia sp.,Nocardia sp.,1821.0,,MIC,ug/L,UO_0000274,0.25
1942,,1866407,CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/Nanomolar,634682,=,1,1,=,MIC,nM,7100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,7.1
1943,,1866436,CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/Nanomolar,634682,=,1,1,=,MIC,nM,7200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,7.2
1944,,1866465,CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/Nanomolar,634682,=,1,1,=,MIC,nM,53500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,53.5
1945,,1866494,CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/Nanomolar,634682,=,1,1,=,MIC,nM,38400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,38.4
1946,,1867853,CHEMBL915055,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,mg/L,UO_0000274,4.0
1947,,1867854,CHEMBL915055,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,8.0
1948,,1867855,CHEMBL915055,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC50,mg/L,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,mg/L,,8.0
1949,,1867856,CHEMBL915055,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC90,mg/L,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,mg/L,,32.0
1950,,1867861,CHEMBL915056,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 43300,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,mg/L,UO_0000274,4.0
1951,,1867862,CHEMBL915056,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 43300,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,8.0
1952,,1867863,CHEMBL915056,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 43300,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC50,mg/L,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,mg/L,,8.0
1953,,1867864,CHEMBL915056,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 43300,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC90,mg/L,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,mg/L,,32.0
1954,,1867901,CHEMBL915057,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,mg/L,UO_0000274,8.0
1955,,1867902,CHEMBL915057,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,mg/L,UO_0000274,16.0
1956,,1867903,CHEMBL915057,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC50,mg/L,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC50,mg/L,,16.0
1957,,1867904,CHEMBL915057,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC90,mg/L,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC90,mg/L,,64.0
1958,,1867925,CHEMBL915058,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,mg/L,UO_0000274,16.0
1959,,1867926,CHEMBL915058,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,mg/L,UO_0000274,32.0
1960,,1867927,CHEMBL915058,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC50,mg/L,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC50,mg/L,,16.0
1961,,1867928,CHEMBL915058,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC90,mg/L,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC90,mg/L,,64.0
1962,,1867949,CHEMBL915059,Antimicrobial activity against Streptococcus pyogenes ATCC 19615,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,mg/L,UO_0000274,4.0
1963,,1867950,CHEMBL915059,Antimicrobial activity against Streptococcus pyogenes ATCC 19615,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634758,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,mg/L,UO_0000274,8.0
1964,,1867951,CHEMBL915059,Antimicrobial activity against Streptococcus pyogenes ATCC 19615,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC50,mg/L,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MBC50,mg/L,,8.0
1965,,1867952,CHEMBL915059,Antimicrobial activity against Streptococcus pyogenes ATCC 19615,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1146200,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,634758,=,1,0,=,MBC90,mg/L,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MBC90,mg/L,,16.0
1966,,1868263,CHEMBL919275,Antibacterial activity against Neisseria meningitidis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634866,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.12
1967,,1868264,CHEMBL919275,Antibacterial activity against Neisseria meningitidis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634866,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.12
1968,,1868414,CHEMBL920714,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634658,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,4.0
1969,,1868415,CHEMBL920714,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634658,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
1970,,1868431,CHEMBL920715,Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent susceptible isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://qudt.org/vocab/unit#Percent,634658,=,1,0,=,Activity,%,24.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,24.4
1971,,1868465,CHEMBL920716,Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://qudt.org/vocab/unit#Percent,634658,=,1,0,=,Activity,%,38.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,38.8
1972,,1997536,CHEMBL899975,Antibacterial activity against Staphylococcus aureus Rosenbach after 14 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1137628,Bioorg Med Chem Lett,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,665327,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
1973,,2026539,CHEMBL887179,Antimycobacterial activity against Mycobacterium tuberculosis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1139205,Bioorg Med Chem Lett,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,673039,>,1,1,>,MIC,ug.mL-1,6.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,6.25
1974,Not Determined,2026554,CHEMBL887177,Inhibition of HIV1 recombinant integrase 3'-processing activity,B,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1139205,Bioorg Med Chem Lett,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,673039,,1,0,,IC50,,,CHEMBL3471,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 integrase,11676.0,,IC50,,,
1975,Not Determined,2026560,CHEMBL887178,Inhibition of HIV1 recombinant integrase strand transfer activity,B,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1139205,Bioorg Med Chem Lett,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,673039,,1,0,,IC50,,,CHEMBL3471,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 integrase,11676.0,,IC50,,,
1976,,2026566,CHEMBL887174,Antiviral activity against HIV1 3B in CEM cells assessed as inhibition of viral-induced cytopathicity,F,BAO_0000188,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1139205,Bioorg Med Chem Lett,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/Nanomolar,673039,>,1,1,>,EC50,nM,52100.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,EC50,uM,UO_0000065,52.1
1977,,2123380,CHEMBL936226,Antimicrobial activity against carbapenem-intermediate or resistant Acinetobacter baumannii isolates by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143837,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703281,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,mg/L,UO_0000274,0.5
1978,,2123383,CHEMBL936226,Antimicrobial activity against carbapenem-intermediate or resistant Acinetobacter baumannii isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143837,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703281,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,mg/L,UO_0000274,8.0
1979,,2123399,CHEMBL936228,Antimicrobial activity against carbapenem-intermediate or resistant Acinetobacter baumannii assessed as percent susceptible isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143837,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://qudt.org/vocab/unit#Percent,703281,=,1,0,=,Activity,%,77.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,77.0
1980,Active,2125237,CHEMBL937014,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by silicone disk biofilm colonization method,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145511,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,705845,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1981,Active,2125240,CHEMBL937015,Antibacterial activity against methicillin-resistant Staphylococcus aureus at 4 hrs daily exposure for 2 days,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145511,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,,705845,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
1982,,2127014,CHEMBL936772,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae FH,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.5
1983,,2127018,CHEMBL936773,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae Mac,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
1984,,2127022,CHEMBL936774,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae M129,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
1985,,2127026,CHEMBL936775,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2063G mutant isolate 1,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
1986,,2127030,CHEMBL935914,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2063G mutant isolate 6,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
1987,,2127034,CHEMBL935916,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 4,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
1988,,2127038,CHEMBL935915,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 2,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
1989,,2128680,CHEMBL940188,Antimicrobial activity against Acinetobacter baumannii D54 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.125
1990,,2128681,CHEMBL940190,Antimicrobial activity against Acinetobacter baumannii A24 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
1991,,2128682,CHEMBL940192,Antimicrobial activity against Acinetobacter baumannii A24 in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
1992,,2128683,CHEMBL940194,Antimicrobial activity against Acinetobacter baumannii A24A after 4 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
1993,,2128684,CHEMBL939407,Antimicrobial activity against Acinetobacter baumannii A24B after 4 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
1994,,2128685,CHEMBL939409,Antimicrobial activity against Acinetobacter baumannii A24C after 4 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
1995,,2128686,CHEMBL939411,Antimicrobial activity against Acinetobacter baumannii A24D after 4 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
1996,,2128687,CHEMBL939413,Antimicrobial activity against Acinetobacter baumannii A24D after 4 days in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
1997,,2128688,CHEMBL939415,Antimicrobial activity against Acinetobacter baumannii B46 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
1998,,2128689,CHEMBL921721,Antimicrobial activity against Acinetobacter baumannii B46 in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
1999,,2128690,CHEMBL921723,Antimicrobial activity against Acinetobacter baumannii C75 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,CHEMBL1434,MINOCYCLINE,CHEMBL1434,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704437,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
